<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7746453</article-id><article-id pub-id-type="doi">10.1155/2020/3972390</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Natural Products: Review for Their Effects of Anti-HBV</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9345-5631</contrib-id><name><surname>Liu</surname><given-names>Xuqiang</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1583-9741</contrib-id><name><surname>Ma</surname><given-names>Changyang</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0053-1923</contrib-id><name><surname>Liu</surname><given-names>Zhenhua</given-names></name><email>liuzhenhua623@163.com</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1822-6249</contrib-id><name><surname>Kang</surname><given-names>Wenyi</given-names></name><email>kangweny@hotmail.com</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>National R &#x00026; D Center for Edible Fungus Processing Technology, Henan University, Kaifeng 475004, China</aff><aff id="I2">
<sup>2</sup>Functional Food Engineering Technology Research Center, Henan Province, Kaifeng 475004, China</aff><aff id="I3">
<sup>3</sup>Joint International Research Laboratory of Food &#x00026; Medicine Resource Function, Henan University, Kaifeng, 475004 Henan Province, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Abdul Ahad</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>9</day><month>12</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>3972390</elocation-id><history><date date-type="received"><day>10</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>13</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Xuqiang Liu et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Hepatitis B is a global infectious disease, seriously endangering human health. Currently, there are mainly interferons and nucleoside analogues treatment of hepatitis B in the clinic, which have certain therapeutic effects on hepatitis B, but their side effects and drug resistance are increasingly prominent. Therefore, it is urgently needed to discover and develop new anti-HBV drugs, especially natural products, which have novel, high efficiency, and low toxicity anti-HBV compounds with novel antiviral mechanisms. In this manuscript, the natural products (polysaccharides and 165 compounds) with the activity of antihepatitis B virus are discussed according to their chemical classes, including 14 phenylpropanoids, 8 flavonoids,12 xanthones, 13 anthroquinones, 47 terpenoids, 6 alkaloids, 15 enediynes, 11 aromatics, 18 phenylalanine dipeptides compounds, and 13 others. In addition, the anti-HBV mechanism and targets of natural product were also discussed. The aim of this review is to report new discoveries about anti-HBV natural products and to provide reference for researchers.</p></abstract><funding-group><award-group><funding-source>Key Project in Science and Technology of Henan Province</funding-source><award-id>182102410083</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Viral hepatitis B, referred to as hepatitis B, is a disease caused by the infection of hepatitis B virus (HBV, <xref ref-type="fig" rid="fig1">Figure 1</xref>). The infection of HBV can cause liver failure, acute or chronic hepatitis, cirrhosis, and even hepatocellular carcinoma (HCC). About 2 billion people worldwide are infected with HBV, of which 400 million are long-term carriers [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. According to research reports by the World Health Organization (WHO), about 600,000 people die of HBV infection or liver diseases related to HBV infection every year [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. China has the largest population of HBV-infected people worldwide and is confronting this large disease burden with efficient antiviral drugs.</p><p>At present, there are mainly two kinds of drugs used in the clinic, namely, interferons (INFs) with antiviral and immunoregulatory functions and nucleoside analogues that can inhibit the reverse transcription of HBV [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. In recent years, although these drugs have a certain therapeutic effect on HBV infection in the clinic, there are serious side effects and drug resistance [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Thus, there are more and more researchers focus on natural product [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>]. Some researches report a variety of natural medicines with novel structure and anti-HBV activity, including some candidate drugs with good anti-HBV effects. However, these reports were mainly involved in isolation and identification of compounds with anti-HBV activity; the mechanisms and targets of compounds were less. The mechanism of clinical medicines (nucleoside analogues and interferon) on anti-HBV is basically clear, but the emergence of drug-resistant HBV mutants weakens the clinical effects. Thus, the development of safe and effective anti-HBV drugs with novel mechanism is the top priority in the current research [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B12" ref-type="bibr">12</xref>]. In this manuscript, in order to help researchers understand HBV and develop the anti-HBV drugs, all kinds of natural products (<xref rid="tab1" ref-type="table">Table 1</xref>) with anti-HBV effects and the infection process of HBV (<xref ref-type="fig" rid="fig1">Figure 1</xref>) [<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>] were summarized. The types of natural products with anti-HBV activity include phenylpropanoids, flavonoids, alkaloids, terpenes, glycosides, and others (such as lactones and organic acids).</p></sec><sec id="sec2"><title>2. The Natural Products of Anti-HBV</title><sec id="sec2.1"><title>2.1. Phenylpropanoids</title><p>Phenylpropanins have a wide range of biological activities, including antitumor, antivirus, liver protection, and antioxidation. For example, a variety of lignans in fruits of <italic>Schisandra chinensis</italic> have liver protective effects and can reduce serum alanine aminotransferase level. Schisandrae esteril A and its analogues have been used in the treatment of chronic hepatitis in China [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>6-Hydroxyl-7-methoxyl-coumarin (<bold>1</bold>), isolated from the <italic>Streblus asper</italic> Lour core material, had significant anti-HBV effect on HepG 2.2.15 cells [<xref rid="B19" ref-type="bibr">19</xref>]. And the mechanism of compound <bold>1</bold> on anti-HBV effect may be related to its inhibition on secretion of hepatitis B virus surface antigen (HBsAg) and hepatitis B virus e antigen (HBeAg), and the IC<sub>50</sub> were 29.60&#x02009;<italic>&#x003bc;</italic>M (selective index, SI = 6.76) and 46.41&#x02009;<italic>&#x003bc;</italic>M (SI = 4.31), respectively. Esculetin (<bold>2</bold>) from <italic>Microsorium fortunei</italic> (Moore) Ching. could not only inhibit the expression of the HBV antigens and HBV-DNA but also inhibit the expression of hepatitis B virus X(HBx) protein in a dose-dependent manner [<xref rid="B20" ref-type="bibr">20</xref>]. Chen et al. [<xref rid="B21" ref-type="bibr">21</xref>] isolated a series of phenylpropanins from the core material, bark and root of <italic>S. asper</italic>, all of which had significant anti-HBV activity. Among them, Magnatriol B (<bold>3</bold>) showed moderate anti-HBV activity by inhibiting the secretion of HBsAg and HBeAg with low cytotoxicity. Honokiol (<bold>4</bold>) showed significant anti-HBV activity and strong inhibition on HBsAg and HBeAg with IC<sub>50</sub> of 3.14&#x02009;<italic>&#x003bc;</italic>M (SI = 21.47) and 4.74&#x02009;<italic>&#x003bc;</italic>M (SI = 14.22), respectively. The inhibition effect of honokiol on HBsAg and HBeAg was stronger than that of positive control, lamivudine. Isomagnolol (<bold>5</bold>) and isocarpine (<bold>6</bold>) from the bark and roots of <italic>S. asper</italic> showed significant anti-HBV activity by HepG 2.2.15 cell assay and significantly inhibited HBsAg secretion with IC<sub>50</sub> of 10.34&#x02009;<italic>&#x003bc;</italic>M and 3.67&#x02009;<italic>&#x003bc;</italic>M, respectively. For inhibiting the secretion of HBeAg, IC<sub>50</sub> was 8.83&#x02009;<italic>&#x003bc;</italic>M and 14.67&#x02009;<italic>&#x003bc;</italic>M, respectively, without cytotoxicity. Honokiol (<bold>7</bold>) and (7&#x02032;<italic>R</italic>, 8&#x02032;<italic>S</italic>, 7&#x02032;<italic>R</italic>, 8&#x02032;<italic>S</italic>)-erythron-Strebluslignanol G (<bold>8</bold>), isolated from methanol extract of roots of <italic>S. asper</italic>, have strong anti-HBV activity by inhibiting the secretion of HBsAg and HBeAg. In addition, compounds <bold>7</bold>and <bold>8</bold> could significantly inhibit the replication of HBV-DNA, with IC<sub>50</sub> of 9.02 and 8.67&#x02009;<italic>&#x003bc;</italic>M, respectively [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. Coumarin lignan (<bold>9</bold>) isolated from the stem of <italic>Kadsura heteroclita</italic> could inhibit the production of HBsAg and HBeAg with concentration of 25&#x02009;<italic>&#x003bc;</italic>g/mL. The inhibition of compound <bold>9</bold> (57% and 48%) was even better than that of positive control, lamivudine (10% and 46%) [<xref rid="B24" ref-type="bibr">24</xref>]. Niranthin (<bold>10</bold>), isolated from <italic>Phyllanthus niruri</italic>, could inhibit the secretion of HBsAg and HBeAg in dose-dependent, with IC<sub>50</sub> values of 16.5&#x02009;<italic>&#x003bc;</italic>M and 25.1&#x02009;<italic>&#x003bc;</italic>M. The inhibition rates of <bold>10</bold> on HBsAg and HBeAg were 90.4% and 83.1% with 55.5&#x02009;<italic>&#x003bc;</italic>M while the inhibition rates of lamivudine were 55.6% and 44.5% with 43.6&#x02009;<italic>&#x003bc;</italic>M. The anti-HBV effect of compound <bold>10</bold> was better than that of lamivudine. The inhibition rates of compound <bold>10</bold> on DHBV-DNA, HBsAg, and HBeAg were higher than that of lamivudine, and the recovery rate was smaller after drug withdrawal, indicating that compound <bold>10</bold> had a good prospect in the development of new anti-HBV drugs <italic>in vivo</italic> [<xref rid="B25" ref-type="bibr">25</xref>]. (+)-Dehydrod-iconiferyl alcohol (<bold>11</bold>) and dehydrozingerone (<bold>12</bold>) showed moderate inhibitory activities on the secretion of HBsAg with IC<sub>50</sub> value of 1.94&#x02009;mM (SI 1.06) and 0.50&#x02009;mM (SI 2.88) [<xref rid="B26" ref-type="bibr">26</xref>]. (+)-Cycloolivil-4&#x02032;-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>13</bold>) and syringaresinol 4<sup>&#x02033;</sup>-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>14</bold>) showed inhibitory activity on HBsAg secretion with IC<sub>50</sub> values of 0.31 &#x000b1; 0.045 and 1.49 &#x000b1; 0.033&#x02009;mM. In particular, compound <bold>13</bold> exhibited inhibition not only on the secretions of HBsAg and HBeAg with IC<sub>50</sub> values of 0.31 &#x000b1; 0.045&#x02009;mM (SI = 4.29) and 0.77 &#x000b1; 0.076&#x02009;mM (SI = 1.75), respectively, but also on HBV DNA replication with an IC<sub>50</sub> value of 0.29 &#x000b1; 0.034&#x02009;mM (SI = 4.66) [<xref rid="B27" ref-type="bibr">27</xref>]. The chemical structures of compounds <bold>1</bold>~<bold>14</bold> showed in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></sec><sec id="sec2.2"><title>2.2. Flavonoids</title><p>Flavonoids have a wide range of biological activities, including anti-inflammatory, anticancer, and antibacterial. It has a prominent role in protecting liver; for example, silymarin shows significant effect on protecting liver and has successfully developed into a protect liver medicine [<xref rid="B28" ref-type="bibr">28</xref>].</p><p>Recently, flavonoids have been reported with good anti-HBV effect. Luteolin (<bold>15</bold>), isolated from <italic>Swertia macrosperma</italic> C. B. Clark, could significantly inhibit the secretion of HBsAg and HBeAg with IC<sub>50</sub> values of 0.02&#x02009;mM on HepG 2.2.15 cells <italic>in vitro</italic> [<xref rid="B29" ref-type="bibr">29</xref>]. Isovitexin (<bold>16</bold>) isolated from <italic>S. yunnanensis</italic> had good anti-HBV effect, which could not only inhibit the secretion of HBsAg and HBeAg, with IC<sub>50</sub> values of 0.04&#x02009;mM, &#x0003c;0.03&#x02009;mM, and 0.23&#x02009;mM, but also significantly inhibit the replication of HBV-DNA, with the IC<sub>50</sub> values of 0.09&#x02009;mM, &#x0003c;0.01&#x02009;mM, and 0.05&#x02009;mM [<xref rid="B30" ref-type="bibr">30</xref>]. Huang et al. [<xref rid="B31" ref-type="bibr">31</xref>] isolated LPRP-Et-97543 (<bold>17</bold>) from <italic>Liriopemuscari</italic> (Decne.) L.H.Bailey, which had significant anti-HBV activity and could significantly reduce the activity of Core, S, and preS promoters. Moreover, the mechanism may be that it inhibited the replication of viral DNA by regulating viral proteins. In recent years, molecular docking technology was used to screen the active ingredients against HBV, a 3D structure of HBV polymerase (Pol/RT) was modeled and docked with the active compounds, and quercetin (<bold>18</bold>) was proved that could enhance its anti-HBV activity up to 10% [<xref rid="B32" ref-type="bibr">32</xref>]. In addition, some researchers found that glabaarachalcone (<bold>19</bold>) and isopongachromene (<bold>20</bold>), isolated from <italic>P. pinnata</italic>, could bound with HBV-DNA polymerase protein target [<xref rid="B33" ref-type="bibr">33</xref>]. Isooriention (<bold>21</bold>), isolated from <italic>S. mussotii</italic>, displayed significant anti-HBV activities against the secretions of HBsAg and HBeAg with IC<sub>50</sub> value of 0.79 and 1.12&#x02009;mM, as well as HBV-DNA replication with IC<sub>50</sub> value of 0.02&#x02009;mM [<xref rid="B34" ref-type="bibr">34</xref>]. Epimedium Hyde II (<bold>22</bold>), a potential Chinese herbal active ingredient against HBV, could inhibit the replication of HBV-DNA and the expression of HBsAg and HBeAg in the serum of HBV-replicated C57BL/6 mice [<xref rid="B35" ref-type="bibr">35</xref>]. The chemical structures of compounds <bold>15</bold>~22 showed in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></sec><sec id="sec2.3"><title>2.3. Xanthones</title><p>Norbellidifolin (<bold>23</bold>), 1,5,8-trihydroxy-3-methoxyxanthone (<bold>24</bold>), 2-C-<italic>&#x003b2;</italic>-D-glucopyranosyl-1,3,7-trihydroxyxanthone (<bold>25</bold>), norswertianolin (<bold>26</bold>), norswertianin-1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucoside (<bold>27</bold>), 1,7-dihydroxy-3,8-dimethoxyxanthone (<bold>28</bold>), 7-<italic>O</italic>-[<italic>&#x003b2;</italic>-D-xylopyranosyl-(1&#x02009;&#x02192;&#x02009;2)-<italic>&#x003b2;</italic>-D-xylopyranosyl]-1,8-dihydroxy-3-methoxyxanthone (<bold>29</bold>), and mangiferin (<bold>30</bold>) showed remarkable inhibition on HBV-DNA replication with IC<sub>50</sub> values from 0.01&#x02009;mM to 0.13&#x02009;mM. Compounds <bold>23</bold>-<bold>25</bold> with three or more hydroxy groups showed significant inhibitory activity with IC<sub>50</sub> values of 0.77, &#x0003e;0.98, and 0.21&#x02009;mM for HBsAg, and &#x0003c;0.62, 0.35, and 0.04&#x02009;mM for HBeAg, respectively. It was deduced that hydroxy groups in the xanthone structure were essential for maintaining the inhibitory effects on the secretion of HBsAg and HBeAg. Glycosidation of hydroxy groups led to activity decreasing against HBsAg and HBeAg by comparing the activity of compounds <bold>24</bold>, <bold>26</bold>, and <bold>27</bold>. It was concluded that two or more hydroxy groups were essential for inhibiting HBV-DNA replication, and methylation of hydroxy groups decreased or abolished anti-HBV activity. In addition, the position of the hydroxy groups of the isolated xanthones did not significantly affect the inhibition on HBV-DNA replication. The preliminary structure-activity relationships were deduced as (1) the anti-HBV activity of xanthones depends on the structure and substitution pattern of the hydroxy groups; (2) the hydroxy groups play very important roles in the anti-HBV activity; (3) the anti-HBV activity will be decreased after methylation orglycosidation [<xref rid="B36" ref-type="bibr">36</xref>]. Methyl6,8-dihydroxy-3-methyl-9-oxo-9H-xanthene-1-carboxylate (<bold>31</bold>), isolated from mangrove-derived aciduric fungus <italic>Penicillium</italic> sp., inhibited HBsAg secretion more effectively than that of the positive control, 3TC, in a dose-dependent manner [<xref rid="B37" ref-type="bibr">37</xref>]. 1,8-Dihydroxy-3,5-dimethoxyxanthone (<bold>32</bold>), norswertianolin (<bold>33</bold>), and neolancerin (<bold>34</bold>), isolated from <italic>S. yunnanensis</italic>, had good anti-HBV effect. Among of them, compound <bold>34</bold> could not only inhibit the secretion of HBsAg and HBeAg, with IC<sub>50</sub> values of 0.21, 0.10, and 1.51, but also significantly inhibit the replication of HBV-DNA, with the IC<sub>50</sub> values of 0.09&#x02009;mM, &#x0003c;0.01&#x02009;mM, and 0.05&#x02009;mM. However, compounds <bold>32</bold> and <bold>33</bold> only showed inhibitory effect on HBV-DNA replication, which may be caused by methylation or glycoylation of the hydroxyl group of the compounds [<xref rid="B30" ref-type="bibr">30</xref>]. 1,5,8-Trihydroxy-3-methoxyxanthone (<bold>35</bold>) exhibited significant inhibitory activity on HBV-DNA replication with IC<sub>50</sub> values of 0. 09 and 0. 05&#x02009;m&#x02009;mol&#x000b7;L<sup>&#x02212;1</sup> (SI of 10. 89) and showed potent activity against the secretion of HBeAg with IC<sub>50</sub> values of 0. 35 (SI of &#x02265;2. 80) [<xref rid="B38" ref-type="bibr">38</xref>]. The chemical structures of compounds <bold>23</bold>~35 are shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></sec><sec id="sec2.4"><title>2.4. Anthroquinones</title><p>Anthroquinones, often found in the metabolites of lichens and fungi of higher plants and lower plants, have the functions of hemostasis, antisepsis, purgation, and diuretic. In recent years, the anti-HBV activity of anthroquinones was reported [<xref rid="B39" ref-type="bibr">39</xref>].</p><p>(&#x02212;)-2&#x02032;<italic>R</italic>-1-hydroxyisorhodoptilometrin (<bold>36</bold>), asterric acid (<bold>37</bold>), questinol (<bold>38</bold>), endo crocin (<bold>39</bold>), (+)-2&#x02032;<italic>S</italic>-isorhodoptilometrin (<bold>40</bold>), sulochrin (<bold>41</bold>), monochlorsulochrin (<bold>42</bold>), and dihydrogeodin (<bold>43</bold>) were isolated from mangrove-derived aciduric fungus <italic>Penicillium</italic> sp. and inhibited HBsAg secretion more effectively than that of the positive control, 3TC, in a dose-dependent manner. Compared with 13% inhibition by 3TC, compounds <bold>36</bold> and <bold>42</bold> at 20&#x02009;<italic>&#x003bc;</italic>M inhibited HBeAg secretion by 17 and 35%, respectively. Compound <bold>36</bold> showed much stronger antihepatitis B virus activity than that of the positive control, lamivudine, strongly inhibiting the secretion on HBsAg and HBeAg of HepG 2.2.15 cells. These results showed that extremophiles are a valuable resource of bioactive compounds, and that pH regulation is an effective strategy to induce metabolite production in aciduric fungi [<xref rid="B37" ref-type="bibr">37</xref>]. Peng et al. [<xref rid="B40" ref-type="bibr">40</xref>] found that 1,3-dihydroxy-2-hydroxymethyl-9,10-anthraquinone (<bold>44</bold>), Rubiadin (<bold>45</bold>), and Anthraquinone bile acid conjugates (<bold>46</bold>) have significant anti-HBV effects on HepG2.2.15 cells. The IC<sub>50</sub> values of them were 12.41, 8.03, 17.05, and 8.13&#x02009;g/mL, respectively. When the drug concentrations were 8&#x02009;g/mL, the inhibitory rates of HBeAg were 61.42%, 43.79%, and 69.30%, respectively. The inhibitory rates of HBsAg secreted by cells were 6.15%, 23.34%, and 43.38%, respectively. Particularly, compound <bold>45</bold> could not only significantly decrease HBeAg and HBsAg secretion level and inhibit HBV-DNA replication but also inhibit the proliferation of the cells and HBx protein expression in a dose-dependent manner, which might become a novel anti-HBV drug candidate. Mohammad K et al. [<xref rid="B41" ref-type="bibr">41</xref>] reported that anti-HBV potential of AV-derived anthroquinones, possibly via HBV-DNA polymerase inhibition for the first time. Although aloin B <bold>(47)</bold> exhibited novel antiviral effect, aloe-emodin (<bold>48</bold>) appeared as the most promising anti-HBV natural drug with CYP3A4 activating property towards its enhanced therapeutic efficacy. Lan et al. [<xref rid="B42" ref-type="bibr">42</xref>] found that hypericin <bold>(49)</bold> could significantly reduce the expression of HBV-DNA and the expression level of HBsAg and HBeAg, which was similar to lamivudine, 3TC. The chemical structures of compounds <bold>36</bold>~49 are shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p></sec><sec id="sec2.5"><title>2.5. Terpenoids</title><p>Terpenes are a kind of compounds with isoprene as the basic structural unit. Terpenes have extensive biological activities, mainly including anti-inflammatory and antiviral effects [<xref rid="B43" ref-type="bibr">43</xref>].</p><p>Li et al. [<xref rid="B19" ref-type="bibr">19</xref>] isolated ursolic acid (<bold>50</bold>) from <italic>S. asper</italic> core material. Compound <bold>50</bold> had strong anti-HBV activity by inhibiting the production of HBsAg and HBeAg, with IC<sub>50</sub> of 89.91 and 97.61&#x02009;<italic>&#x003bc;</italic>M. A triterpenoid, named MH (<bold>51</bold>), was isolated from the <italic>Vicia tenuifolia</italic> Roth, which had significant inhibitory effect on the secretion of HBsAg and HBeAg in a dose-dependent manner [<xref rid="B44" ref-type="bibr">44</xref>]. Sweriyunnangenin A (<bold>52</bold>), 3-epitaraxerol (<bold>53</bold>), oleanolic acid (<bold>54</bold>), and erythrocentaurin (<bold>55</bold>), isolated from <italic>S. yunnanensis</italic>, could inhibit the secretion of HBsAg with IC<sub>50</sub> values of 0.28, 0.70, and 1.26&#x02009;mM, respectively. They also had good inhibitory effects on the secretion of HBeAg, with the IC<sub>50</sub> values of 0.29, 1.41, and 0.94&#x02009;mM, respectively. Especially, compound <bold>55</bold> could effectively inhibit the secretion of HBsAg and HBeAg, as well as the replication of HBV-DNA, due to its aldehyde group [<xref rid="B26" ref-type="bibr">26</xref>]. Zhou et al. [<xref rid="B45" ref-type="bibr">45</xref>] isolated a series of heptane terpenoids from the roots and rhizomes of <italic>Aster tataricus</italic> L. f. Among them, astataricusones B andepishionol (<bold>56-57</bold>) could inhibit the secretion of HBeAg, with IC<sub>50</sub> value of 18.6 and 40.5&#x02009;<italic>&#x003bc;</italic>M, and the replication HBV-DNA, with IC<sub>50</sub> value of 2.7 and 30.7&#x02009;<italic>&#x003bc;</italic>M. In addition, compound <bold>56</bold> had inhibitory effect on the secretion of HBsAg with IC<sub>50</sub> value of 23.5&#x02009;<italic>&#x003bc;</italic>M. Zhou et al. [<xref rid="B46" ref-type="bibr">46</xref>] carried out further research on <italic>A. tataricus</italic>, and 6 new shionane-type triterpenes were isolated. Among them, astershionones C (<bold>58</bold>) had good anti-HBV activity by inhibiting the secretion of HBsAg and HBeAg and the replication of HBV-DNA with IC<sub>50</sub> values of 23.0, 23.1, and 22.4&#x02009;<italic>&#x003bc;</italic>M, respectively. Bi et al. [<xref rid="B47" ref-type="bibr">47</xref>] found that 7 monoterpenes (4<sup>&#x02033;</sup>-hydroxy-3<sup>&#x02033;</sup>-methoxyalbiflorin (<bold>59</bold>), 6&#x02032;-<italic>O</italic>-<italic>p</italic>-hydroxybenzoyl-4<sup>&#x02033;</sup>-Hydroxyalbiflorin (<bold>60</bold>), albiflorin (<bold>61</bold>), oxypaeoniflorin (<bold>62</bold>), paeoniflorin (<bold>63</bold>),paeonins B (<bold>64</bold>), and benzoylpaeoniflorin (<bold>65</bold>)) of the <italic>Paeonia sinjiangensis</italic> K. Y. Pan had anti-HBV activity and could inhibit the secretion of HBsAg and HBeAg as well as the replication of HBV-DNA. Among them, compound <bold>59</bold> had the highest anti-HBV activity, which was even better than that of positive drug, 3TC. Perovskatone A and demethylsalvicanol (<bold>66-67)</bold>, isolated from <italic>Perovskia atriplicifolia</italic>, had anti-HBV activity. It was for the first report on the anti-HBV effect of <italic>P. atriplicifolia</italic> [<xref rid="B48" ref-type="bibr">48</xref>]. Chrysanolide B-C and A (<bold>68-70</bold>) were isolated from <italic>Dendranthema indicum</italic>, and compound <bold>70</bold> had unknown trimer carbon skeleton. Compounds <bold>68-70</bold> had good anti-HBV activity on HepG 2.2.15 cell, and their anti-HBV activity was positively correlated with the degree of polymerization [<xref rid="B49" ref-type="bibr">49</xref>]. In the anti-HBV test, Pimelotides A (<bold>71</bold>) showed significant inhibition on the secretion of HBsAg, with an IC<sub>50</sub> value of 0.016&#x02009;g/mL and TI up to 355.63. However, the anti-HBV mechanism of compound <bold>71</bold> should be carried out for the further study [<xref rid="B50" ref-type="bibr">50</xref>]. Genkwanine P (<bold>73</bold>) and laurifolioside A (<bold>74</bold>), isolated from <italic>Wikstroemia chamaedaphne</italic> Meisn, exhibited potential antihepatitis B virus activities with IC<sub>50</sub> values of 46.5 and 88.3&#x02009;mg/mL, respectively. Wikstroelide W (<bold>72</bold>), 2-epi-laurifolioside A (<bold>75</bold>), laurifolioside B (<bold>76</bold>), 2-epi-laurifolioside B (<bold>77</bold>),laurifolioside (<bold>78</bold>), and 2-epi-laurifolioside (<bold>79</bold>) showed certain inhibitory effects on HBV-DNA replication with the inhibition ratios ranging from 2.0% to 33.0% at the concentrations ranging from 0.39 to 6.25&#x02009;mg/mL [<xref rid="B51" ref-type="bibr">51</xref>]. It is reported that the extracts of <italic>Alternantheraphiloxeroides</italic> (Mart.) Griseb have antiviral properties <italic>in vitro</italic>. And oleanolic acid 3-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucuronopyranoside (<bold>80</bold>) and 4,5-dihydroblumenol (<bold>81</bold>), isolated from the extracts, showed significant inhibition against HepG2.2.15 cells transected with cloned HBV-DNA; their inhibitive ratios were 85.38% and 87.37% at 50&#x02009;<italic>&#x003bc;</italic>g/mL, respectively [<xref rid="B52" ref-type="bibr">52</xref>]. Nine compounds <bold>82-89</bold> isolated from <italic>S. cincta</italic>, namely, swericinctosides A (<bold>82</bold>), swericinctoside B (<bold>83</bold>), 9-epi swertiamarin (<bold>84</bold>), 2&#x02032;-<italic>O</italic>-m-hydroxybenzoyl swertiamarin (<bold>85</bold>), 4<sup>&#x02033;</sup>-<italic>O</italic>-actyl swertianoside E (<bold>86</bold>), swertiaside (<bold>87</bold>), swertianoside C (<bold>88</bold>), and decentapicrin B (<bold>89</bold>), possessed inhibitory activity on HBV-DNA replication with IC<sub>50</sub> values from 0.05 to 1.83&#x02009;mM. Compounds <bold>82</bold>, <bold>84</bold>, and <bold>86-88</bold> showed moderate activity against HBsAg with IC<sub>50</sub> values in the range of 0.24&#x02013;2.46&#x02009;mM, and compounds <bold>82</bold>, <bold>84</bold>, <bold>87</bold>, and <bold>88</bold> could inhibit HBV-DNA replication with IC<sub>50</sub> values of 0.30&#x02013;0.62&#x02009;mM. Compound <bold>87</bold> exhibited the most promising activity against HBV-DNA replication with an IC<sub>50</sub> value of 0.05&#x02009;mM (SI = 29.1), as well as moderate activity against the HBsAg secretion (IC<sub>50</sub> = 0.79&#x02009;mM) [<xref rid="B53" ref-type="bibr">53</xref>]. Geng et al. [<xref rid="B54" ref-type="bibr">54</xref>] found that the anti-HBV activity of erythrocentaurin (ET) derivatives was significantly improved. In particular, ET derivatives 1e and 1f (<bold>90</bold>, <bold>91</bold>) showed the highest activity of inhibiting the replication of HBV-DNA, with IC<sub>50</sub> values of 0.026&#x02009;mM (SI &#x0003e; 70.8) and 0.045&#x02009;mM (SI &#x0003e; 36.0), respectively. Swertiakoside A (<bold>92</bold>) and 2&#x02032;-<italic>O</italic>-acetylswertiamarin (<bold>93</bold>) exhibited significant inhibitory activity on HBV-DNA replication with IC<sub>50</sub>values from 0.05 to 1.46&#x02009;mmol&#x000b7;L<sup>&#x02212;1</sup> [<xref rid="B38" ref-type="bibr">38</xref>]. Huang et al. [<xref rid="B55" ref-type="bibr">55</xref>] isolated Asiaticoside (<bold>94</bold>) from <italic>Hydrocotyle sibthorpioides</italic> Lam and found that Asiaticoside could effectively inhibit the secretion of HBsAg and HBeAg. In addition, Asiaticoside could significantly reduce the transcription and replication of HBV-DNA by inhibiting the core, s1, s2, and x gene promoter activity. Liu et al. [<xref rid="B56" ref-type="bibr">56</xref>] found diosgenin (<bold>95</bold>) could effectively inhibit the secretion of HBsAg and HBeAg, with the inhibition rate reaching 40% and 50%. 7-Eudesm-4(15)-ene-1<italic>&#x003b2;</italic>,6<italic>&#x003b1;</italic>-diol (<bold>96</bold>) and Pumilaside A (<bold>97</bold>), isolated from <italic>Artemisia capillaris</italic>, exhibited promising activity against HBV-DNA replication with IC<sub>50</sub> values of 19.70 and 12.01&#x02009;<italic>&#x003bc;</italic>M, with high SI values of 105.5 and 139.2. In addition, compound <bold>97</bold> could also suppress the secretions of HBsAg and HBeAg with the IC<sub>50</sub> values of 15.02&#x02009;<italic>&#x003bc;</italic>M (SI = 111.3) and 9.00&#x02009;<italic>&#x003bc;</italic>M (SI = 185.9) [<xref rid="B57" ref-type="bibr">57</xref>]. The chemical structures of compounds <bold>50</bold>~97 showed in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p></sec><sec id="sec2.6"><title>2.6. Alkaloids</title><p>Alkaloids, a kind of natural nitrogen heterocyclic, have complex ring structure, most of which have physiological activity [<xref rid="B58" ref-type="bibr">58</xref>].</p><p>Jiang et al. [<xref rid="B59" ref-type="bibr">59</xref>] found that the ethanol extract of <italic>Piper longum</italic> L. fruit had good anti-HBV effect, and erythro-1-[1-oxo-9(3,4-methylenedioxyphenyl)-8,9-dihydroxy-2<italic>E</italic>-nonenyl]-piperidine (<bold>98</bold>), threo-1-[1-oxo-9(3,4-methylenedioxyphenyl)-8,9-dihydroxy-2<italic>E</italic>-nonenyl]-piperidine (<bold>99</bold>), piperine (<bold>100</bold>), guineesine (<bold>101</bold>), and (2<italic>E</italic>,4<italic>E</italic>)-N-isobutyleicosa-2,4-dienamide (<bold>102</bold>) had significant inhibitory effect on the secretion of HBsAg and HBeAg on HepG 2.2.15 cells. 3<italic>&#x003b2;</italic>,4<italic>&#x003b1;</italic>-dihydroxy-1-(3-phenylpropanoyl)-piperidine-2-one (<bold>103</bold>), isolated from <italic>P. longum</italic> ethanol extract, had significant anti-HBV activity and could inhibit the secretion of HBsAg and HBeAg, with IC<sub>50</sub> of 1.80 and 0.21&#x02009;mM, respectively. The selectivity of compound <bold>103</bold> on HBeAg inhibition was up to 16.4, which was better than that of positive drug, 3TC, and has a good development prospect [<xref rid="B60" ref-type="bibr">60</xref>]. Zeng et al. [<xref rid="B61" ref-type="bibr">61</xref>] obtained a quaternary ammonium alkaloid DHCH (<bold>104</bold>) from <italic>Corydalis saxicola</italic> Bunting, which could significantly inhibit the secretion of HBsAg and HBeAg on HepG2.2.15 cells, with TI of 7.32 and 6.77, respectively. Further study showed that compound <bold>104</bold> could reduce the levels of cccDNA and DNA in dose and time dependence manner, with IC<sub>50</sub> values of 15.08, 7.62, and 8.25&#x02009;<italic>&#x003bc;</italic>M, respectively. The chemical structures of compounds <bold>98</bold>~104 are shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>.</p></sec><sec id="sec2.7"><title>2.7. Enediynes</title><p>
<italic>A. capillaris</italic> (Yin-Chen) is a famous traditional Chinese medicine (TCM) for treating acute and chronic hepatitis in China [<xref rid="B62" ref-type="bibr">62</xref>]. Geng et al. [<xref rid="B63" ref-type="bibr">63</xref>] isolated 14 compounds, 8<italic>S</italic>-deca-9-en-4,6-diyne-1,8-diol (<bold>105</bold>), (<italic>S</italic>)-deca-4,6,8-triyne-1,3-diol (<bold>106</bold>), (<italic>S</italic>)-3-hydroxyundeca-5,7,9-triynoic acid (<bold>107</bold>), 3<italic>S</italic>-Hydroxyundeca-5,9-triynoic acid 3-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>108</bold>), Atractylodin (<bold>109</bold>), Dendroarboreol B (<bold>110</bold>), Dehydrofalcarinol (<bold>111</bold>), Dehydrofalcarindiol (<bold>112</bold>), (<italic>E</italic>)-deca-2-en-4,10-diol (<bold>113</bold>), (<italic>Z</italic>)-deca-2-en-4,10-diol (<bold>114</bold>), 8-diol 1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>115</bold>), 3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-ene-4,6-diyne 1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>116</bold>), 5-benzylthiophencarboxylic acid (<bold>117</bold>), and 2-methyl-6-phenyl-4H-pyran-4-one (<bold>118</bold>), from <italic>A. capillaris</italic>. All the compounds were assayed for their anti-HBV activity, and the structure-activity relationships were summarized based on the biological effects. In particular, compound <bold>108</bold> could significantly inhibit the secretions of HBsAg, HBeAg, and HBV-DNA replication with IC<sub>50</sub> values of 197.2 (SI &#x0003e; 5.1), 48.7 (SI &#x0003e; 20.5), and 9.8 (SI &#x0003e; 102) <italic>&#x003bc;</italic>M. Hydroxyl and glycosyl groups are preferable for maintaining activity. In subsequent studies, Geng et al. [<xref rid="B64" ref-type="bibr">64</xref>] found that 3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-en-4,6-yne 1-<italic>O</italic>-(6&#x02032;-O-caffeoyl)-<italic>&#x003b2;</italic>-D-glucopyranoside and 3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-en-4,6-yne 1-<italic>O</italic>-(2&#x02032;-<italic>O</italic>-caffeoyl)-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>119-120</bold>) had the activity against the secretions of HBsAg and HBeAg and HBV DNA replication. Especially, compounds <bold>119</bold> and <bold>120</bold> inhibited HBV-DNA replication with IC<sub>50</sub> values of 0.077 &#x000b1; 0.04 and 0.0127 &#x000b1; 0.05&#x02009;mM, with SI values of 23.6 and 17.1, respectively. Compounds <bold>119</bold> and <bold>120</bold> as a pair of isomers showed similar inhibition on HBsAg secretion with IC<sub>50</sub> values of 0.797 &#x000b1; 0.23&#x02009;mM (SI = 2.1) and 0.887 &#x000b1; 0.20&#x02009;mM (SI&#x02009;=2.3), but no activity against HBeAg secretion. Compound <bold>119</bold> displayed the highest inhibitory activity on HBV-DNA replication with an IC<sub>50</sub> value of 0.077 &#x000b1; 0.04&#x02009;mM (SI = 23.6), and compound <bold>120</bold> showed slightly decreased activity with an IC<sub>50</sub> value of 0.127 &#x000b1; 0.05&#x02009;mM (SI = 17.1). The above analyses suggested that the caffeoyl group played important role in maintaining the anti-HBV activity but the substitution position may not be crucial. The chemical structures of compounds <bold>105</bold>~120 are shown in <xref ref-type="fig" rid="fig8">Figure 8</xref>.</p></sec><sec id="sec2.8"><title>2.8. Aromatics</title><p>Six phenols, <italic>m</italic>-hydroxybenzoic acid (<bold>121</bold>), <italic>p</italic>-hydroxybenzoic acid (<bold>122</bold>), <italic>m</italic>-hydroxy benzenmethanol (<bold>123</bold>), 3,4-dihydroxybenzoic acid (<bold>124</bold>), ethyl 3,4-dihydroxybenzoate (<bold>125</bold>), and ethyl 2,5-dihydroxybenzoate (<bold>126</bold>), exhibited anti-HBV activities by inhibiting HBsAg and HBeAg secretion with IC<sub>50</sub> values from 0.23 to 5.18&#x02009;mM, and HBV-DNA replication with IC<sub>50</sub> values from 0.06 to 2.62&#x02009;mM. Compounds <bold>121</bold>-<bold>123</bold>, with one hydroxyl and one carboxyl, showed anti-HBV activity with IC<sub>50</sub> values of 3.76, 5.18, and 4.55&#x02009;mM for inhibitory HBsAg secretion and 2.36, 2.54, and 2.62&#x02009;mM for inhibitory HBV-DNA replication, respectively. Compounds <bold>124</bold>-<bold>126</bold> with two hydroxyls and one carboxyl displayed remarkable inhibition on HBV-DNA replication with IC<sub>50</sub> values of &#x0003c;0.06, 0.22, and 0.29&#x02009;mM. Furthermore, compounds <bold>125</bold> and <bold>126</bold> showed significant inhibitory effect on the secretion of HBsAg (IC<sub>50</sub> = 0.14 and 0.23&#x02009;mM) and HBeAg (IC<sub>50</sub> = 5.03 and 3.74&#x02009;mM) [<xref rid="B34" ref-type="bibr">34</xref>].</p><p>3,3&#x02032;,5-Trihydroxybiphenyl <bold>(127</bold>), isolated from <italic>S. chirayita</italic>, showed activity against HBeAg secretion with IC <sub>50</sub> values of 0.77 &#x000b1; 0.076 and 5.92 &#x000b1; 1.02&#x02009;mM [<xref rid="B27" ref-type="bibr">27</xref>]. Taraffinisoside A (<bold>128</bold>), descaffeoyl crenatoside (<bold>129</bold>), and 3,4-dihydroxyphenylethanol-8-<italic>O</italic>-[<italic>&#x003b2;</italic>-D-apiofuranosyl (1&#x02009;&#x02192;&#x02009;3)]-<italic>&#x003b2;</italic>-D-glucopyranoside (<bold>130</bold>) isolated from <italic>Tarphochlamys affinis</italic> (Griff.) could inhibit the secretion of HBsAg and HBeAg [<xref rid="B65" ref-type="bibr">65</xref>]. Huang et al. [<xref rid="B66" ref-type="bibr">66</xref>] isolated <italic>p</italic>-hydroxy acetophenone (PHAP) (<bold>131</bold>) from <italic>A. morrisonensis</italic>, which could significantly inhibit the replication of HBV. The mechanism may be that PHAP was involved in regulating the expression of surface protein genes and blocks the release of virus particles by interfering with the signaling pathway of endoplasmic reticulum. Zhao et al. [<xref rid="B67" ref-type="bibr">67</xref>] found that PHAP and derivatives have good anti-HBV activity, and structural modification on p-HAP and its glycoside led to a series of derivatives; among them, <italic>p</italic>-HAP derivative 2f (<bold>132</bold>) had the strongest effect on inhibiting the replication HBV-DNA (IC<sub>50</sub> = 5.8&#x02009;<italic>&#x003bc;</italic>M, SI = 160.3). The primary structure-activity relationships suggested that the conjugated derivatives of <italic>p</italic>-HAP glycoside and substituted cinnamic acids obviously enhanced the activity against HBV-DNA replication. The chemical structures of compounds <bold>121</bold>~132 are shown in <xref ref-type="fig" rid="fig9">Figure 9</xref>.</p></sec><sec id="sec2.9"><title>2.9. Phenylalanine Dipeptides</title><p>Yang et al. [<xref rid="B68" ref-type="bibr">68</xref>] isolated and modified the phenylalanine dipeptide Matijin-Su (<bold>133</bold>) with anti-HBV activity from <italic>Dichondra repens</italic> Forst, and four derivatives were screened with anti-HBV activity <italic>in vitro</italic>. Yang et al. [<xref rid="B69" ref-type="bibr">69</xref>] found that compound <bold>101</bold> could inhibit the replication of HBV-DNA, with IC<sub>50</sub> value of 1.33&#x02009;<italic>&#x003bc;</italic>M, and inhibit the replication of various mutant HBV strains. Xu et al. [<xref rid="B70" ref-type="bibr">70</xref>] synthesized a series of MTS derivatives with anti-HBV activity by the design of the Matijin-Su (MTS). One of the preferred MTS derivatives (Y101) was conducted in the clinical preclinical study and received the clinical approval of the CFDA.</p><p>Kuang et al. [<xref rid="B71" ref-type="bibr">71</xref>] used the compound MTS as lead compound; a novel MTS derivative was designed and synthesized by introducing the structure unit of veratrol acid; N-[N-(3,4-dimethoxy-benzoyl)-L-phenylalanyl]-<italic>O</italic>-propionyl-L-phenylalaninol (<bold>134</bold>), N-[N-(3,4-dimethoxy-benzoyl)-L-phenylalanyl]-4-ethoxy-L-phenylalaninol (<bold>135</bold>), and N-[N-(3,4-Dimethoxy-benzoyl)-L-phenylalanyl]-4-ethoxycarbonylmethyl-L-tyrosinol (<bold>136</bold>) were tested the anti-HBV activity <italic>in vitro</italic>. All the compounds have the significant anti-HBV activity. Subsequently, a series of MTS derivatives were designed and synthesized with compound MTS as the lead compound, by introducing fluorine or chlorine substitution, and the obtained MTS derivatives were tested for anti-HBV activity <italic>in vitro</italic>. N-[N-(4-chlorobenzoyl)-<italic>O</italic>-methyl-L-tyrosyl]-L-Phenylalaninol (<bold>137</bold>), N-[N-(4-chlorobenzoyl)-<italic>O</italic>-propyl-L-tyrosyl]-L-Phenylalaninol (<bold>138</bold>), and N-[N-(4-chlorobenzoyl)-<italic>O</italic>-isopropyl-L-tyrosyl]-L-Phenylalaninol (<bold>139</bold>) showed good anti-HBV activity, with IC<sub>50</sub> of 12.61, 10.53, and 6.46&#x02009;mol/L, respectively [<xref rid="B72" ref-type="bibr">72</xref>]. Cui et al. [<xref rid="B73" ref-type="bibr">73</xref>] synthesized 20 MTS derivatives containing trifluoromethyl substitution and tested the anti-HBV activity of the synthesized target compound in HepG 2.2.15 cells <italic>in vitro</italic>. Among them, N-[N-(3-trifluoromethylbenzoyl)-L-tyrosyl]-L-Phenylalaninol (<bold>140</bold>), N-[N-(3-trifluoromethylbenzoyl)-L-phenylalanyl]-<italic>O</italic>-propionyl-L-tyrosine methyl ester (<bold>141</bold>), and N-[N-(3-trifluoromethylbenzoyl)-L-phenylalanyl]-<italic>O</italic>-ethyl-L-tyrosine (<bold>142</bold>) showed strong anti-HBV activity, and their IC<sub>50</sub> reached 11.74, 8.73, and 11.41&#x02009;mol&#x000b7;L<sup>&#x02212;1</sup>.</p><p>Jang et al. [<xref rid="B74" ref-type="bibr">74</xref>] synthesized twenty novel <italic>n</italic>-methyl derivatives of MTS, among which compounds 8n (<bold>143</bold>) and 8o (<bold>144</bold>) showed certain anti-HBV activity, with IC<sub>50</sub> of 52.5&#x02009;mol&#x000b7;L<sup>&#x02212;1</sup> and 49.2&#x02009;mol&#x000b7;L<sup>&#x02212;1</sup>, respectively. Compounds 9 a-c(<bold>145-147</bold>) were triantennary cluster galactosides of MTS with potential for hepatic targeting. The anti-HBV activities of those were evaluated in HepG 2.2.15 cells. And all those compounds had inhibitory effect on HBV-DNA replication in HepG2 2.2.15 cells in a dose-response manner [<xref rid="B75" ref-type="bibr">75</xref>]. Huang et al. [<xref rid="B76" ref-type="bibr">76</xref>] evaluated the 20 species of marine natural small molecule compounds by HepG 2.2.15 cell lines; three kinds of compounds cyclic (glycine-L-proline) (<bold>148</bold>), cyclic (4-hydroxy proline-phenylalanine) (<bold>149</bold>), and cyclic (L-2-hydroxy proline-phenylalanine) (<bold>150</bold>) had anti-HBV activity on the inhibition of HBsAg, HBeAg, and HBV-DNA, with the treatment of index greater than 2. N-acetyl phenylalanine (<bold>151</bold>) had certain inhibitory effects on HBsAg and HBeAg with the IC<sub>50</sub> values of 55.5, 69.5&#x02009;<italic>&#x003bc;</italic>g/mL, respectively [<xref rid="B77" ref-type="bibr">77</xref>]. The chemical structures of compounds <bold>133-151</bold> are shown in <xref ref-type="fig" rid="fig10">Figure 10</xref>.</p></sec><sec id="sec2.10"><title>2.10. Others</title><sec id="sec2.10.1"><title>2.10.1. Lactones</title><p>Two dimers of oxanthrone andiridoid lactone (<bold>152, 153</bold>) were isolated from <italic>S. punicea</italic>, which could inhibit the secretion of HBsAg with IC<sub>50</sub> value of 0.25 and 0.29&#x02009;mM, and the secretion of HBeAg with IC<sub>50</sub> value of 0.86 and 0.31&#x02009;mM. In addition, compounds <bold>152</bold>-<bold>153</bold> also could inhibit the replication of HBV-DNA, with the IC<sub>50</sub> values of 0.18 and 0.19&#x02009;mM, respectively [<xref rid="B78" ref-type="bibr">78</xref>]. Anislactone B (<bold>154</bold>), a kind of nor sesquiterpene lactone with unique structure from the fruit of <italic>Illicium henryi</italic>, had high anti-HBV activity and could inhibit the secretion of HBeAg on HepG 2.2.15 cell with IC<sub>50</sub>0.079 &#x000b1; 0.035&#x02009;mM<italic>in vitro</italic> [<xref rid="B79" ref-type="bibr">79</xref>].</p></sec><sec id="sec2.10.2"><title>2.10.2. Isosteviol</title><p>The analogue of isosteviol, NC-8 (<bold>155</bold>), had anti-HBV activity by inhibiting the secretion of HBsAg and HBeAg, with the IC<sub>50</sub> value of 7.89&#x02009;g/mL, which was better than that of the positive control (lamivudine). The mechanism of NC-8 was interfering with HBV replication and gene expression and blocking the TLR2/NF-<italic>&#x003ba;</italic>b signaling pathway of host cells. It is for the first report of isosteviol analogues against HBV [<xref rid="B80" ref-type="bibr">80</xref>]. Huang et al. [<xref rid="B81" ref-type="bibr">81</xref>] got a series of new derivatives, including the IN-4 (<bold>156</bold>) with high anti-HBV activity. The mechanism might be that IN-4 suppressed the expression of HBV gene and the replication of HBV-DNA by interfering with the NF-<italic>&#x003ba;</italic>B signaling pathways of host cell.</p></sec><sec id="sec2.10.3"><title>2.10.3. Organic Acids</title><p>Scoparamide A (<bold>157</bold>) could inhibit not only the secretions of HBsAg and HBeAg with IC<sub>50</sub> values of 0.617 &#x000b1; 0.25&#x02009;mM (SI = 2.1) and 0.887 &#x000b1; 0.25&#x02009;mM (SI = 1.4), respectively, but also HBV-DNA replication with an IC<sub>50</sub> value of 0.477 &#x000b1; 0.14&#x02009;mM (SI = 2.7) [<xref rid="B64" ref-type="bibr">64</xref>]. Zhang et al. [<xref rid="B82" ref-type="bibr">82</xref>] isolated cichoric acid (<bold>158</bold>) from the leaves of <italic>Chicory intybus</italic> L and found that it had significant anti-HBV activity. Rosmarinic acid (<bold>159</bold>) inhibits HBV replication in HBV-infected cells by specifically targeting <italic>&#x003b5;</italic>-Pol binding. In addition, they analyzed an additional 25 rosmarinic acid derivatives and found that the &#x0201c;two phenolic hydroxyl groups at both ends&#x0201d; and the &#x0201c;caffeic acid-like structure&#x0201d; of rosmarinic acid are critical for the inhibition of <italic>&#x003b5;</italic>-Pol binding [<xref rid="B83" ref-type="bibr">83</xref>]. It is well known that phenolic acids have better antiviral activity. The studies showed that 3-caffeoylquinicacid <bold>(160)</bold> [<xref rid="B84" ref-type="bibr">84</xref>] could inhibit the secretion of HBsAg, HBeAg, and the replication of HBV-DNA on Hep G 2.2.15 cells at the concentration of 100&#x02009;<italic>&#x003bc;</italic>g/mL. In order to reveal the anti-HBV activity and structure-activity relationships of the analogues of chlorogenic acid, 9 chlorogenic acid analogues were evaluated on HepG 2.2.15 cell lines <italic>in vitro</italic> and found that chlorogenic acid, cryptochlorogenic acid (<bold>161</bold>), neochlorogenic acid (<bold>162</bold>), 3,5-dicaffeoylquinic acid (<bold>163</bold>), 4,5-dicaffeoylquinic acid (<bold>164</bold>), and 3,4-dicaffeoylquinic acid (<bold>165</bold>) possessed potent activity against HBV-DNA replication with IC<sub>50</sub> values in the range of 5.5 &#x000b1; 0.9-13.7 &#x000b1; 1.3&#x02009;<italic>&#x003bc;</italic>M. Di-caffeoyl analogues (<bold>163-165</bold>) also exhibited activity against the secretions of HBsAg and HBeAg. The number of caffeoyl moiety may contribute to the inhibitory activity against HBsAg and HBeAg secretions, while the position of caffeoyl units play little role on anti-HBV-DNA activities. In addition, carboxyl group is closely associated to the antiviral activity [<xref rid="B85" ref-type="bibr">85</xref>]. The chemical structures of compounds <bold>152</bold>~165 are shown in <xref ref-type="fig" rid="fig11">Figure 11</xref>.</p></sec><sec id="sec2.10.4"><title>2.10.4. Polysaccharides</title><p>Natural polysaccharide is mainly referred to widely exists in the nature of cellulose and its derivatives, chitin, and other natural polymer materials. Polysaccharides have a wide range of biological activities, such as enhanced immunity, antiviral, and anti-inflammatory [<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B87" ref-type="bibr">87</xref>].</p><p>In recent years, clinical researches of natural polysaccharides on anti-HBV have increased gradually; they have been proved to have significant anti-HBV effect [<xref rid="B88" ref-type="bibr">88</xref>]. Lentinan polysaccharide has a prominent effect on antiviral and immune regulation and is also used as an auxiliary drug for cancer and HBV [<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B90" ref-type="bibr">90</xref>]. Zhao et al. [<xref rid="B91" ref-type="bibr">91</xref>] obtain two polysaccharide fractions (LEP-1 and LEP-2) from <italic>Lentinus edodes</italic> (Berk.) sing. They found that LEPs possess potent anti-HBV activity <italic>in vitro</italic>. In addition, the polysaccharides from <italic>Hedyotis caudatifolia</italic> Merr.et Metcalf (50, 100, and 200&#x02009;mg/L) significantly inhibited the secretion and expression of HBV-DNA on HepG 2.2.15 cells and effectively inhibited the secretion of HBsAg and HBeAg. Its mechanism may be related to the activation of JAK/STAT signaling pathway and the promotion of antiviral protein expression [<xref rid="B92" ref-type="bibr">92</xref>]. Zhan et al. [<xref rid="B93" ref-type="bibr">93</xref>] found that snail polysaccharides have a certain inhibitory effect on the replication of HBV-DNA (<italic>P</italic> &#x0003c; 0.01), which indicated that the maximum inhibition rate of HBsAg and HBeAg in HepG 2.2.15 cells is 42.8% and 52.1%, respectively, slightly below the positive control group (<italic>P</italic> &#x0003c; 0.05), and the inhibition effect of snail polysaccharide on HBeAg was better than that of HBsAg. The results of real-time fluorescence quantitative PCR test showed that snail polysaccharide had a certain inhibitory effect on the replication of HBV-DNA (<italic>P</italic> &#x0003c; 0.011). The anti-HBV effect of polyporus polysaccharide may be related to the regulation of the body's immune function, breaking the body's immune tolerance or low state [<xref rid="B94" ref-type="bibr">94</xref>]. <italic>Angelica sinensis</italic> polysaccharide [<xref rid="B95" ref-type="bibr">95</xref>] could promote DC mature of HBV transgenic mice, raise its coordinated stimulus molecules on the surface, enhance its promoting lymphocyte proliferation and secretion, strengthen its antigen oral ability, induce cellular immune response, reduce serum concentrations of HBsAg, and play a role in antiviral immunity. Liu et al. [<xref rid="B96" ref-type="bibr">96</xref>] extracted Chinese whelk polysaccharide by water extraction and transfected human hepatocellular carcinoma cells with HBV-DNA cloning as an experimental model. The results showed that PCC significantly inhibited HBV-DNA in HepG 2.2.15 cells at 0.1&#x02009;mg&#x000b7;mL<sup>&#x02212;1</sup> and 1&#x02009;mg&#x000b7;mL<sup>&#x02212;1</sup>. Xia et al. [<xref rid="B97" ref-type="bibr">97</xref>] investigated the effect of polysaccharides of <italic>Sipunculus nudus</italic> Linnaeus on anti-HBV; the results showed that polysaccharide with different dose groups were different degree of inhibition of HBV-DNA replication (<italic>P</italic> &#x0003c; 0.05), and the effects of high, middle dose group were similar to acyclovir.</p></sec></sec></sec><sec id="sec3"><title>3. Conclusion and Perspectives</title><p>At present, a variety of natural products with novel structure and high anti-HBV activity were isolated from natural resources. Among them, we found that terpenoids with antihepatitis B activity are the most (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref rid="tab1" ref-type="table">Table 1</xref>), and the activity is more significant.</p><p>However, the research content were disorderly and mainly focus on the simple isolation and identification of anti-HBV activity ingredients; the in-depth studies of anti-HBV mechanisms and targets are relatively rare. Moreover, most of the studies are limited to cell level, lack of animal model experiments, and no in-depth research of ingredients with significant antihepatitis B activity. Therefore, there are three suggestions for product research and development:</p><sec id="sec3.1"><title>3.1. Search for New Natural Product Resources</title><p>The research on natural products against hepatitis B mainly focuses on the field of traditional Chinese medicine on land. The research on traditional Chinese medicine against hepatitis b has been very matured. However, it is still difficult to develop active natural products against HBV. In addition, there are few researches on marine natural products, microbial fermentation products, plant polysaccharides, and other aspects. In recent years, studies have found that marine natural products have good biological activity due to their special growth environment. Huang et al. [<xref rid="B76" ref-type="bibr">76</xref>] screened significant anti-HBV active ingredients from small marine molecules. Microbial fermentation products are a novel source of natural products. In recent years, many novel compounds are derived from microbial fermentation products. It is an interesting way to study the anti-HBV activity of microbial fermentation products. Plant polysaccharides have a wide range of biological activities, and studies [<xref rid="B88" ref-type="bibr">88</xref>&#x02013;<xref rid="B95" ref-type="bibr">95</xref>] have shown that the chemical components of polysaccharides have a good anti-HBV activity. It is of great significance to search for anti-HBV active ingredients from novel natural products.</p></sec><sec id="sec3.2"><title>3.2. Novel Method for Screening</title><p>The traditional screening of anti-HBV activity involves the separation and identification of chemical components in traditional Chinese medicinal materials and then the screening of their activity, which often takes time and effort and is difficult to obtain accurate screening results. In recent years, researchers used computer-aided drug design (molecular simulation docking) to screen out suitable compounds from the database and then carried out screening <italic>in vitro</italic>. This method has strong purpose and high accuracy. A series of derivatives with good anti-HBV activity were obtained by modifying the structure of known compounds with anti-HBV activity, and the derivatives with the best activity were screened out through activity test. This method also provides a new idea for discovering anti-HBV compounds with better activity [<xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B75" ref-type="bibr">75</xref>].</p></sec><sec id="sec3.3"><title>3.3. Synergy Effect</title><p>Single-chemical components of natural products are no longer effective against HBV, and drug resistance will appear. For example, artemisinin is combined with other components to fight malaria. In anti-HBV studies, treatment methods of combination drugs are also widely used [<xref rid="B98" ref-type="bibr">98</xref>].</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Key Project in Science and Technology of Henan Province (182102410083).</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The data used to support the findings of this study are available from the corresponding author upon request.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec><title>Authors' Contributions</title><p>All authors contributed to the manuscript. W.K. and Z.L. conceived this subject. X.L. and C.M. searched, collected, and analyzed the relevant literature, as well as prepared the first draft. W.K. and X.L. critically read and revised the paper. All authors read and approved the final manuscript.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohlfarth</surname><given-names>C.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Natural products as promising drug candidates for the treatment of hepatitis B and C</article-title><source><italic toggle="yes">Acta Pharmacologica Sinica</italic></source><year>2009</year><volume>30</volume><issue>1</issue><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/aps.2008.5</pub-id><pub-id pub-id-type="other">2-s2.0-64849111443</pub-id><?supplied-pmid 19060918?><pub-id pub-id-type="pmid">19060918</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safioleas</surname><given-names>M.</given-names></name><name><surname>Lygidakis</surname><given-names>N. J.</given-names></name><name><surname>Manti</surname><given-names>C.</given-names></name></person-group><article-title>Hepatitis B today</article-title><source><italic toggle="yes">Hepato-Gastroenterology</italic></source><year>2007</year><volume>54</volume><issue>74</issue><fpage>545</fpage><lpage>548</lpage><?supplied-pmid 17523319?><pub-id pub-id-type="pmid">17523319</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="other"><collab>World Health Organisation</collab><article-title>Hepatitis B, factsheet, No.204</article-title><year>2014</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/Mediacentre/factsheets/fs204/en/1">https://www.who.int/Mediacentre/factsheets/fs204/en/1</ext-link></comment></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>W. S.</given-names></name></person-group><source><italic toggle="yes">Cancer Associated Viruses</italic></source><year>2012</year><publisher-loc>New York</publisher-loc><publisher-name>Springer-Verlag New York Inc.</publisher-name></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nassal</surname><given-names>M.</given-names></name></person-group><article-title>New insights into HBV replication: new opportunities for improved therapies</article-title><source><italic toggle="yes">Future Virology</italic></source><year>2009</year><volume>4</volume><issue>1</issue><fpage>55</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.2217/17460794.4.1.55</pub-id><pub-id pub-id-type="other">2-s2.0-70349215530</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y. T.</given-names></name><name><surname>Huang</surname><given-names>J. W.</given-names></name><name><surname>Xu</surname><given-names>R. A.</given-names></name><name><surname>Cui</surname><given-names>X. L.</given-names></name></person-group><article-title>Progress in recent study of anti-HBV natural products and extracts</article-title><source><italic toggle="yes">Mini-reviews in Organic Chemistry</italic></source><year>2013</year><volume>10</volume><issue>3</issue><fpage>241</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.2174/1570193X11310030004</pub-id><pub-id pub-id-type="other">2-s2.0-84882788712</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>M. Z.</given-names></name><name><surname>Qin</surname><given-names>G.</given-names></name></person-group><article-title>Research advances in anti-hepatitis B virus drugs</article-title><source><italic toggle="yes">Clinical Gastroenterology and Hepatology</italic></source><year>2019</year><volume>35</volume><issue>10</issue><fpage>2302</fpage><lpage>2307</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z. C.</given-names></name><name><surname>Zhao</surname><given-names>K. T.</given-names></name><name><surname>Jiang</surname><given-names>Y. A.</given-names></name></person-group><article-title>Development of antiviral drugs against hepatitis B virus (in Chinese)</article-title><source><italic toggle="yes">Chinese Science Bulletin</italic></source><year>2019</year><volume>64</volume><fpage>3123</fpage><lpage>3141</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>H.</given-names></name><name><surname>Arbab</surname><given-names>M. K. P.</given-names></name><name><surname>Mohammed</surname><given-names>S. A. D.</given-names></name><name><surname>Adnan</surname><given-names>J. A. R.</given-names></name></person-group><article-title>In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus</article-title><source><italic toggle="yes">Experimental and Therapeutic Medicine</italic></source><year>2017</year><volume>14</volume><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">28672977</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Z. H.</given-names></name><name><surname>Chen</surname><given-names>X. M.</given-names></name></person-group><article-title>Research progress on the active constituents of Chinese traditional medicine for anti HBV</article-title><source><italic toggle="yes">Journal of Liaoning University</italic></source><year>2016</year><volume>18</volume><issue>11</issue><fpage>112</fpage><lpage>115</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X. C.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>B. K.</given-names></name><name><surname>Xu</surname><given-names>Z. Y.</given-names></name></person-group><article-title>Molecular docking and in vitro screening of active anti-hepatitis B virus components from Abrus cantoniensis</article-title><source><italic toggle="yes">The Chinese Journal of Clinical Pharmacology</italic></source><year>2019</year><volume>35</volume><issue>5</issue><fpage>439</fpage><lpage>441</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y. T.</given-names></name><name><surname>Xu</surname><given-names>R. A.</given-names></name><name><surname>Cui</surname><given-names>X. L.</given-names></name></person-group><article-title>Progress in anti-hepatitis B virus natural drugs targeting different sites</article-title><source><italic toggle="yes">Chinese Journal of Pharmacology and Toxicology</italic></source><year>2012</year><volume>26</volume><issue>5</issue><fpage>702</fpage><lpage>705</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S. P.</given-names></name><name><surname>Li</surname><given-names>J. S.</given-names></name><name><surname>Wands</surname><given-names>J. R.</given-names></name></person-group><article-title>Affecting B virus genetic conventions: biological properties and clinical implications</article-title><source><italic toggle="yes">Emerging Microbes and Infections</italic></source><year>2019</year><volume>2</volume><issue>3</issue><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. L.</given-names></name><name><surname>Wang</surname><given-names>R. X.</given-names></name><name><surname>Hou</surname><given-names>W. B.</given-names></name></person-group><article-title>Anti-viral components of natural products</article-title><source><italic toggle="yes">Natural Product Research and Development</italic></source><year>2007</year><volume>19</volume><fpage>179</fpage><lpage>182</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J. M.</given-names></name></person-group><article-title>Advances in the structure and function of HBV open reading frame</article-title><source><italic toggle="yes">International Journal of Digestive Diseases</italic></source><year>2008</year><volume>28</volume><issue>2</issue><fpage>114</fpage><lpage>116</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname><given-names>D.</given-names></name><name><surname>Thimme</surname><given-names>R.</given-names></name><name><surname>Blum</surname><given-names>H. E.</given-names></name></person-group><article-title>HBV life cycle and novel drug targets</article-title><source><italic toggle="yes">Hepatology International</italic></source><year>2011</year><volume>5</volume><issue>2</issue><fpage>644</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1007/s12072-011-9261-3</pub-id><pub-id pub-id-type="other">2-s2.0-79956271873</pub-id><?supplied-pmid 21484123?><pub-id pub-id-type="pmid">21484123</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>S.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name><name><surname>Dandri</surname><given-names>M.</given-names></name></person-group><article-title>The replication cycle of hepatitis B virus</article-title><source><italic toggle="yes">Journal of Hepatology</italic></source><year>2010</year><volume>52</volume><issue>2</issue><fpage>282</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2009.10.031</pub-id><pub-id pub-id-type="other">2-s2.0-75349095571</pub-id><?supplied-pmid 20056291?><pub-id pub-id-type="pmid">20056291</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Wei</surname><given-names>G. W.</given-names></name><name><surname>Qu</surname><given-names>Z. Y.</given-names></name></person-group><article-title>Research progress on hepatoprotective effects of Schissandra chinensis</article-title><source><italic toggle="yes">Journal of Pharmaceutical Research</italic></source><year>2019</year><volume>38</volume><issue>4</issue><fpage>229</fpage><lpage>232</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L. Q.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Lignans from the heartwood of <italic>Streblus asper</italic> and their inhibiting activities to Hepatitis B virus</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2012</year><volume>83</volume><issue>2</issue><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2011.11.008</pub-id><pub-id pub-id-type="other">2-s2.0-84855996062</pub-id><?supplied-pmid 22119765?><pub-id pub-id-type="pmid">22119765</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S. X.</given-names></name><name><surname>Mou</surname><given-names>J. F.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><name><surname>Mo</surname><given-names>Q. H.</given-names></name><name><surname>Zhou</surname><given-names>X. L.</given-names></name></person-group><article-title>Anti-hepatitis B virus activity of esculetin from Microsorium fortunei in vitro and in vivo</article-title><source><italic toggle="yes">Molecules</italic></source><year>2019</year><volume>24</volume><issue>19</issue><fpage>p. 3475</fpage><pub-id pub-id-type="doi">10.3390/molecules24193475</pub-id><pub-id pub-id-type="other">2-s2.0-85072637215</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name></person-group><article-title>Anti-HBV activities of <italic>Streblus asper</italic> and constituents of its roots</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2012</year><volume>83</volume><issue>4</issue><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.01.009</pub-id><pub-id pub-id-type="other">2-s2.0-84862823403</pub-id><pub-id pub-id-type="pmid">22305944</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Meng</surname><given-names>A. P.</given-names></name><name><surname>Guan</surname><given-names>X. L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Anti-hepatitis B virus lignans from the root of <italic>Streblus asper</italic></article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2013</year><volume>23</volume><issue>7</issue><fpage>2238</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.01.046</pub-id><pub-id pub-id-type="other">2-s2.0-84875212617</pub-id><?supplied-pmid 23434030?><pub-id pub-id-type="pmid">23434030</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Guan</surname><given-names>X. L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Anti-hepatitis B virus constituents from the stem bark of <italic>Streblus asper</italic></article-title><source><italic toggle="yes">Phytochemistry</italic></source><year>2012</year><volume>82</volume><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2012.06.023</pub-id><pub-id pub-id-type="other">2-s2.0-84865223639</pub-id><?supplied-pmid 22818524?><pub-id pub-id-type="pmid">22818524</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>J. P.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>H. W.</given-names></name><name><surname>Pang</surname><given-names>T.</given-names></name></person-group><article-title>A coumarin lignanoid from the stems of <italic>Kadsura heteroclita</italic></article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2015</year><volume>25</volume><issue>7</issue><fpage>1506</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.02.022</pub-id><pub-id pub-id-type="other">2-s2.0-84925506391</pub-id><?supplied-pmid 25736995?><pub-id pub-id-type="pmid">25736995</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>W. X.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name></person-group><article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> anti-hepatitis B virus activities of the lignan niranthin isolated from <italic>Phyllanthus niruri L.</italic></article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2014</year><volume>155</volume><issue>2</issue><fpage>1061</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.05.064</pub-id><pub-id pub-id-type="other">2-s2.0-84906937632</pub-id><?supplied-pmid 25009077?><pub-id pub-id-type="pmid">25009077</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>K.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Cao</surname><given-names>T. W.</given-names></name><name><surname>Wang</surname><given-names>H. L.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name></person-group><article-title>Two new secoiridoids and other anti-hepatitis B virus active constituents from Swertia patens</article-title><source><italic toggle="yes">Journal of Asian Natural Products Research</italic></source><year>2016</year><volume>18</volume><issue>6</issue><fpage>528</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">26727588</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>N. J.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Huang</surname><given-names>X. Y.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name></person-group><article-title>Anti-hepatitis B virus active constituents from <italic>Swertia chirayita</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2015</year><volume>100</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.11.011</pub-id><pub-id pub-id-type="other">2-s2.0-84911931677</pub-id><?supplied-pmid 25447162?><pub-id pub-id-type="pmid">25447162</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>W. S.</given-names></name></person-group><article-title>Research progress of flavonoids biological activity</article-title><source><italic toggle="yes">Guangzhou Chemical Industry</italic></source><year>2012</year><volume>40</volume><issue>2</issue><fpage>47</fpage><lpage>50</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H. L.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>Zhang</surname><given-names>X. M.</given-names></name></person-group><article-title>Three new secoiridoids, swermacrolactones A-C and anti-hepatitis B virus activity from <italic>Swertia macrosperma</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2013</year><volume>89</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.06.002</pub-id><pub-id pub-id-type="other">2-s2.0-84885145672</pub-id><?supplied-pmid 23756190?><pub-id pub-id-type="pmid">23756190</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>T. W.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Jiang</surname><given-names>F. Q.</given-names></name></person-group><article-title>Chemical constituents of <italic>Swertia yunnanensis</italic> and their anti-hepatitis B virus activity</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2013</year><volume>89</volume><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.05.023</pub-id><pub-id pub-id-type="other">2-s2.0-84885094538</pub-id><?supplied-pmid 23747320?><pub-id pub-id-type="pmid">23747320</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. J.</given-names></name><name><surname>Tsai</surname><given-names>Y. C.</given-names></name><name><surname>Chiang</surname><given-names>S. Y.</given-names></name><name><surname>Wang</surname><given-names>G. J.</given-names></name></person-group><article-title>Anti-viral effect of a compound isolated from <italic>Liriope platyphylla</italic> against hepatitis B virus <italic>in vitro</italic></article-title><source><italic toggle="yes">Virus Research</italic></source><year>2014</year><volume>192</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2014.07.015</pub-id><pub-id pub-id-type="other">2-s2.0-84908128623</pub-id><?supplied-pmid 25150190?><pub-id pub-id-type="pmid">25150190</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M. K.</given-names></name><name><surname>Tabish</surname><given-names>M. R.</given-names></name><name><surname>Alam</surname><given-names>P.</given-names></name><name><surname>Al-Dosari</surname><given-names>M. S.</given-names></name></person-group><article-title>Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: cell culture and molecular docking study</article-title><source><italic toggle="yes">Saudi Pharmaceutical Journal</italic></source><year>2019</year><volume>27</volume><issue>3</issue><fpage>389</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2018.12.008</pub-id><pub-id pub-id-type="other">2-s2.0-85059469879</pub-id><?supplied-pmid 30976183?><pub-id pub-id-type="pmid">30976183</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathayan</surname><given-names>M.</given-names></name><name><surname>Jayaraman</surname><given-names>S.</given-names></name><name><surname>Kulanthaivel</surname><given-names>L.</given-names></name><name><surname>Suresh</surname><given-names>A.</given-names></name></person-group><article-title>Inhibition studies of HBV DNA polymerase using seed extracts of Pongamia pinnata</article-title><source><italic toggle="yes">Bioinformation</italic></source><year>2019</year><volume>15</volume><issue>7</issue><fpage>506</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.6026/97320630015506</pub-id><?supplied-pmid 31485136?><pub-id pub-id-type="pmid">31485136</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>T. W.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>Zhang</surname><given-names>X. M.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>Chemical constituents of <italic>Swertia mussotii</italic> and their anti-hepatitis B virus activity</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2015</year><volume>102</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2015.01.020</pub-id><pub-id pub-id-type="other">2-s2.0-84923019020</pub-id><?supplied-pmid 25665940?><pub-id pub-id-type="pmid">25665940</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>D. Y.</given-names></name></person-group><source><italic toggle="yes">Experimental Research of Epimedium Hyde II Anti-HBV In Vivo and In Vitro[D]</italic></source><year>2018</year><publisher-name>Zunyi Medical University</publisher-name></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>T. W.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>He</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>H. L.</given-names></name></person-group><article-title>Xanthones with anti-hepatitis B virus activity from Swertia mussotii</article-title><source><italic toggle="yes">Planta Medica</italic></source><year>2013</year><volume>79</volume><issue>8</issue><fpage>679</fpage><lpage>700</lpage></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>S. D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>W. M.</given-names></name></person-group><article-title>Anti-H1N1-virus secondary metabolites from mangrove-derived aciduric fungus Penicillium sp. OUCMDZ-4736</article-title><source><italic toggle="yes">Chinese Journal of Marine Drugs</italic></source><year>2016</year><volume>35</volume><fpage>21</fpage><lpage>28</lpage></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>CAO</surname><given-names>T. W.</given-names></name><name><surname>GENG</surname><given-names>C. A.</given-names></name><name><surname>MA</surname><given-names>Y. B.</given-names></name><name><surname>HE</surname><given-names>K.</given-names></name></person-group><article-title>Chemical constituents of Swertia delavayi and their anti-hepatitis B virus activity</article-title><source><italic toggle="yes">China Journal of Chinese Materia Medica</italic></source><year>2015</year><volume>40</volume><issue>5</issue><fpage>897</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">26087553</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>Z. L.</given-names></name><name><surname>Yu</surname><given-names>C. M.</given-names></name><name><surname>Lin</surname><given-names>W. Y.</given-names></name><name><surname>Hong</surname><given-names>P. Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Research progress on the synthesis of anthraquinones</article-title><source><italic toggle="yes">Chinese Journal of Synthetic Chemistry</italic></source><year>2019</year><volume>9</volume><fpage>747</fpage><lpage>762</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Fang</surname><given-names>G.</given-names></name><name><surname>Peng</surname><given-names>F. H.</given-names></name><name><surname>Pan</surname><given-names>Z. Y.</given-names></name><name><surname>Su</surname><given-names>Z. Y.</given-names></name></person-group><article-title>Effects of Rubiadin isolated from Prismatomeris connata on anti-hepatitis B virus activity in vitro</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2017</year><volume>31</volume><issue>12</issue><fpage>1962</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1002/ptr.5945</pub-id><pub-id pub-id-type="other">2-s2.0-85031489439</pub-id><?supplied-pmid 29044868?><pub-id pub-id-type="pmid">29044868</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M. K.</given-names></name><name><surname>Al-Dosari</surname><given-names>M. S.</given-names></name><name><surname>Alam</surname><given-names>P.</given-names></name><name><surname>Rehman</surname><given-names>M. T.</given-names></name><name><surname>Alajmi</surname><given-names>M. F.</given-names></name></person-group><article-title>The anti-hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2019</year><volume>33</volume><issue>11</issue><fpage>2960</fpage><lpage>2970</lpage><pub-id pub-id-type="doi">10.1002/ptr.6471</pub-id><pub-id pub-id-type="other">2-s2.0-85070767328</pub-id><pub-id pub-id-type="pmid">31410907</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>T. Y.</given-names></name></person-group><source><italic toggle="yes">Research on Anti-HBV Effect and Mechanism of Hypericin</italic></source><year>2016</year><publisher-name>KunMing University of Science and Technology</publisher-name></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J. H.</given-names></name><name><surname>Liu</surname><given-names>W. T.</given-names></name><name><surname>Luo</surname><given-names>H. M.</given-names></name></person-group><article-title>Advances in activities of terpenoids in medicinal plants</article-title><source><italic toggle="yes">Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology</italic></source><year>2018</year><volume>3</volume><fpage>419</fpage><lpage>430</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q. F.</given-names></name><name><surname>Huang</surname><given-names>R. B.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y. X.</given-names></name></person-group><article-title>Antiviral activity of methyl helicterate isolated from <italic>Helicteres angustifolia</italic> (Sterculiaceae) against hepatitis B virus</article-title><source><italic toggle="yes">Antiviral Research</italic></source><year>2013</year><volume>100</volume><issue>2</issue><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.007</pub-id><pub-id pub-id-type="other">2-s2.0-84885361907</pub-id><?supplied-pmid 24055834?><pub-id pub-id-type="pmid">24055834</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W. B.</given-names></name><name><surname>Zeng</surname><given-names>G. Z.</given-names></name><name><surname>Xu</surname><given-names>H. M.</given-names></name><name><surname>He</surname><given-names>W. J.</given-names></name><name><surname>Tan</surname><given-names>N. H.</given-names></name></person-group><article-title>Astataricusones A-D and astataricusol A, five new anti-HBV shionane-type triterpenes from Aster tataricus l. f</article-title><source><italic toggle="yes">Molecules</italic></source><year>2013</year><volume>18</volume><issue>12</issue><fpage>14585</fpage><lpage>14596</lpage><pub-id pub-id-type="doi">10.3390/molecules181214585</pub-id><pub-id pub-id-type="other">2-s2.0-84890892464</pub-id><?supplied-pmid 24287992?><pub-id pub-id-type="pmid">24287992</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W.-B.</given-names></name><name><surname>Zeng</surname><given-names>G.-Z.</given-names></name><name><surname>Xu</surname><given-names>H.-M.</given-names></name><name><surname>He</surname><given-names>W.-J.</given-names></name><name><surname>Zhang</surname><given-names>Y.-M.</given-names></name><name><surname>Tan</surname><given-names>N.-H.</given-names></name></person-group><article-title>Astershionones A-F, six new anti-HBV shionane-type triterpenes from <italic>Aster tataricus</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2014</year><volume>93</volume><fpage>98</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.12.021</pub-id><pub-id pub-id-type="other">2-s2.0-84893111564</pub-id><?supplied-pmid 24393620?><pub-id pub-id-type="pmid">24393620</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name></person-group><article-title>Monoterpenes from paeonia sinjian gensis inhibit the replication of hepatitis B virus</article-title><source><italic toggle="yes">Records of Natural Products</italic></source><year>2013</year><volume>7</volume><issue>4</issue><fpage>346</fpage><lpage>350</lpage></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z. Y.</given-names></name><name><surname>Huang</surname><given-names>C. G.</given-names></name><name><surname>Xiong</surname><given-names>H. B.</given-names></name><name><surname>Tian</surname><given-names>K.</given-names></name></person-group><article-title>Perovskatone A: a novel C<sub>23</sub> terpenoid from <italic>Perovskia atriplicifolia</italic></article-title><source><italic toggle="yes">Tetrahedron Letters</italic></source><year>2013</year><volume>54</volume><issue>29</issue><fpage>3886</fpage><lpage>3888</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.05.056</pub-id><pub-id pub-id-type="other">2-s2.0-84879014017</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Chrysanolide A, an unprecedented sesquiterpenoid trimer from the flowers of Chrysanthemum indicum L</article-title><source><italic toggle="yes">RSC Advances</italic></source><year>2013</year><volume>3</volume><issue>26</issue><fpage>10168</fpage><lpage>10172</lpage><pub-id pub-id-type="doi">10.1039/c3ra23172k</pub-id><pub-id pub-id-type="other">2-s2.0-84881437886</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>P. Y.</given-names></name><name><surname>Chow</surname><given-names>S.</given-names></name><name><surname>Somerville</surname><given-names>M. J.</given-names></name><name><surname>Voss</surname><given-names>J. J. D.</given-names></name><name><surname>Fletcher</surname><given-names>M. T.</given-names></name></person-group><article-title>Pimelotides A and B, diterpenoid ketal-lactone orthoesters with an unprecedented skeleton from Pimelea elongate</article-title><source><italic toggle="yes">Journal of Natural Products</italic></source><year>2009</year><volume>72</volume><issue>12</issue></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z. Q.</given-names></name><name><surname>Li</surname><given-names>S. F.</given-names></name><name><surname>Zhang</surname><given-names>L. W.</given-names></name><name><surname>Chao</surname><given-names>J. B.</given-names></name></person-group><article-title>Chemical constituents from flowers of Wikstroemia chamaedaphne and their anti-hepatitis B virus activity</article-title><source><italic toggle="yes">Chinese Traditional and Herbal Drugs</italic></source><year>2017</year><volume>48</volume><issue>7</issue></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J. B.</given-names></name><name><surname>Liu</surname><given-names>Y. W.</given-names></name><name><surname>Zhang</surname><given-names>Y. W.</given-names></name><name><surname>Teng</surname><given-names>J.</given-names></name><name><surname>Duan</surname><given-names>H. Q.</given-names></name></person-group><article-title>Antivirus constituents from Alternanthera philoxeroides</article-title><source><italic toggle="yes">Chinese Traditional and Herbal Drugs</italic></source><year>2007</year><volume>38</volume><issue>7</issue></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jie</surname><given-names>X.-X.</given-names></name><name><surname>Geng</surname><given-names>C.-A.</given-names></name><name><surname>Huang</surname><given-names>X.-Y.</given-names></name><etal/></person-group><article-title>Five new secoiridoid glycosides and one unusual lactonic enol ketone with anti-HBV activity from <italic>Swertia cincta</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2015</year><volume>102</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2015.02.009</pub-id><pub-id pub-id-type="other">2-s2.0-84923888425</pub-id><?supplied-pmid 25721422?><pub-id pub-id-type="pmid">25721422</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Huang</surname><given-names>X. Y.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>Zhang</surname><given-names>X. M.</given-names></name><name><surname>Chen</surname><given-names>J. J.</given-names></name></person-group><article-title>Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2015</year><volume>25</volume><issue>7</issue><fpage>1568</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.02.009</pub-id><pub-id pub-id-type="other">2-s2.0-84925536403</pub-id><?supplied-pmid 25737009?><pub-id pub-id-type="pmid">25737009</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q. F.</given-names></name><name><surname>Zhang</surname><given-names>S. J.</given-names></name><name><surname>Huang</surname><given-names>R. B.</given-names></name><name><surname>Ling</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Y. X.</given-names></name></person-group><article-title>Isolation and identification of an anti-hepatitis B virus compound from <italic>Hydrocotyle sibthorpioides</italic> Lam</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2013</year><volume>150</volume><issue>2</issue><fpage>568</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.09.009</pub-id><pub-id pub-id-type="other">2-s2.0-84887463491</pub-id><?supplied-pmid 24051027?><pub-id pub-id-type="pmid">24051027</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name></person-group><article-title>Dioscin's antiviral effect in vitro</article-title><source><italic toggle="yes">Virus Research</italic></source><year>2013</year><volume>172</volume><issue>1-2</issue><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.12.001</pub-id><pub-id pub-id-type="other">2-s2.0-84873749830</pub-id><?supplied-pmid 23238077?><pub-id pub-id-type="pmid">23238077</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Sun</surname><given-names>C. L.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>Huang</surname><given-names>X. Y.</given-names></name><name><surname>Cao</surname><given-names>T. W.</given-names></name></person-group><article-title>Polyacetylenes and anti-hepatitis B virus active constituents from <italic>Artemisia capillaris</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2014</year><volume>95</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.03.017</pub-id><pub-id pub-id-type="other">2-s2.0-84898900937</pub-id><?supplied-pmid 24685503?><pub-id pub-id-type="pmid">24685503</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>F. A.</given-names></name></person-group><article-title>Advances in studies on alkaloids compounds</article-title><source><italic toggle="yes">Guangdong Chemical Industry</italic></source><year>2014</year><volume>17</volume><fpage>84</fpage><lpage>85</lpage></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.-Y.</given-names></name><name><surname>Liu</surname><given-names>W.-F.</given-names></name><name><surname>Zhang</surname><given-names>X.-M.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Y.-B.</given-names></name><name><surname>Chen</surname><given-names>J.-J.</given-names></name></person-group><article-title>Anti-HBV active constituents from <italic>Piper longum</italic></article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2013</year><volume>23</volume><issue>7</issue><fpage>2123</fpage><lpage>2127</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.01.118</pub-id><pub-id pub-id-type="other">2-s2.0-84875217995</pub-id><?supplied-pmid 23434420?><pub-id pub-id-type="pmid">23434420</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z. Y.</given-names></name><name><surname>Liu</surname><given-names>W. F.</given-names></name><name><surname>Huang</surname><given-names>C. G.</given-names></name><name><surname>Huang</surname><given-names>X. Z.</given-names></name></person-group><article-title>New amide alkaloids from <italic>Piper longum</italic></article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2013</year><volume>84</volume><issue>3</issue><fpage>222</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.12.001</pub-id><pub-id pub-id-type="other">2-s2.0-84873354664</pub-id><?supplied-pmid 23232323?><pub-id pub-id-type="pmid">23232323</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>F. L.</given-names></name><name><surname>Xiang</surname><given-names>Y. F.</given-names></name><name><surname>Liang</surname><given-names>Z. R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>D. E.</given-names></name><name><surname>Zhu</surname><given-names>S. N.</given-names></name></person-group><article-title>Anti-hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola</article-title><source><italic toggle="yes">Journal of Chinese Medicine</italic></source><year>2013</year><volume>41</volume><issue>1</issue><fpage>119</fpage><lpage>130</lpage></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. P.</given-names></name><name><surname>Qiu</surname><given-names>X. Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name></person-group><article-title>Research progress on pharmacological effect of Artemisiae Scopariae Herba</article-title><source><italic toggle="yes">Chinese Traditional and Herbal Drugs</italic></source><year>2019</year><volume>9</volume><fpage>2235</fpage><lpage>2241</lpage></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>C. A.</given-names></name><name><surname>Yang</surname><given-names>T. H.</given-names></name><name><surname>Huang</surname><given-names>X. Y.</given-names></name><name><surname>Yang</surname><given-names>J. I.</given-names></name><name><surname>Ma</surname><given-names>Y. B.</given-names></name><name><surname>Li</surname><given-names>T. Z.</given-names></name></person-group><article-title>Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2018</year><volume>10</volume><fpage>283</fpage><lpage>289</lpage></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>C.-A.</given-names></name><name><surname>Huang</surname><given-names>X.-Y.</given-names></name><name><surname>Chen</surname><given-names>X.-L.</given-names></name><etal/></person-group><article-title>Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (<italic>Artemisia scoparia</italic>)</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2015</year><volume>176</volume><issue>12</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.10.032</pub-id><pub-id pub-id-type="other">2-s2.0-84946125538</pub-id><?supplied-pmid 26505294?><pub-id pub-id-type="pmid">26505294</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X. L.</given-names></name><name><surname>Wen</surname><given-names>Q. W.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>S. J.</given-names></name><name><surname>Li</surname><given-names>Y. X.</given-names></name></person-group><article-title>A new phenylethanoid glycoside with antioxidant and anti-HBV activity</article-title><source><italic toggle="yes">Archives of Pharmacal Research</italic></source><year>2014</year><volume>37</volume><issue>5</issue><fpage>600</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">23893479</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. J.</given-names></name><name><surname>Liu</surname><given-names>S. H.</given-names></name><name><surname>Kuo</surname><given-names>Y. C.</given-names></name><name><surname>Chen</surname><given-names>C. W.</given-names></name><name><surname>Chou</surname><given-names>S. H.</given-names></name></person-group><article-title>The Antiviral activity of chemical compound isolated from Artemisia morrisonensis against hepatitis B virus in vitro</article-title><source><italic toggle="yes">Antiviral Research</italic></source><year>2014</year><volume>10</volume><issue>1</issue><fpage>97</fpage><lpage>104</lpage></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Geng</surname><given-names>C.-A.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Isolation, synthesis and anti-hepatitis B virus evaluation of _p_ -hydroxyacetophenone derivatives from <italic>Artemisia capillaris</italic></article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry Letters</italic></source><year>2015</year><volume>25</volume><issue>7</issue><fpage>1509</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.02.024</pub-id><pub-id pub-id-type="other">2-s2.0-84925511377</pub-id><?supplied-pmid 25737008?><pub-id pub-id-type="pmid">25737008</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X. X.</given-names></name><name><surname>Cao</surname><given-names>P. X.</given-names></name><name><surname>Huang</surname><given-names>Z. M.</given-names></name><name><surname>Liang</surname><given-names>G. Y.</given-names></name></person-group><article-title>Synthesis and anti-hepatitis B virus activities of Matijin-Su derivatives</article-title><source><italic toggle="yes">Central South Pharmacy</italic></source><year>2014</year><volume>12</volume><issue>2</issue><fpage>97</fpage><lpage>102</lpage></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>L.-p.</given-names></name><name><surname>Chen</surname><given-names>H.-j.</given-names></name><etal/></person-group><article-title>Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation</article-title><source><italic toggle="yes">Acta Pharmacologica Sinica</italic></source><year>2014</year><volume>35</volume><issue>3</issue><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1038/aps.2013.175</pub-id><pub-id pub-id-type="other">2-s2.0-84895556462</pub-id><?supplied-pmid 24487969?><pub-id pub-id-type="pmid">24487969</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B. X.</given-names></name><name><surname>Huang</surname><given-names>Z. M.</given-names></name><name><surname>Liu</surname><given-names>C. X.</given-names></name><name><surname>Cai</surname><given-names>Z. G.</given-names></name></person-group><article-title>Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source><year>2009</year><volume>17</volume><issue>8</issue><fpage>3118</fpage><lpage>3125</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2009.03.003</pub-id><pub-id pub-id-type="other">2-s2.0-64349097834</pub-id><pub-id pub-id-type="pmid">19307124</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>A. X.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Zeng</surname><given-names>X. P.</given-names></name><name><surname>Liang</surname><given-names>G. Y.</given-names></name><name><surname>Xu</surname><given-names>B. X.</given-names></name></person-group><article-title>Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing veratric acid</article-title><source><italic toggle="yes">Chinese Journal of New Drugs</italic></source><year>2019</year><volume>28</volume><issue>12</issue></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>A. X.</given-names></name><name><surname>Zeng</surname><given-names>X. P.</given-names></name><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Liang</surname><given-names>G. Y.</given-names></name><name><surname>Xu</surname><given-names>B. X.</given-names></name></person-group><article-title>Synthesis and anti-HBV activity evaluation of fluorine or chlorine-substituted derivatives of Matijin-Su</article-title><source><italic toggle="yes">Journal of Guizhou Medical University</italic></source><year>2019</year><volume>4</volume><issue>4</issue><fpage>418</fpage><lpage>422</lpage></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Qiu</surname><given-names>J. Y.</given-names></name><name><surname>Zeng</surname><given-names>X. P.</given-names></name><name><surname>Liang</surname><given-names>G. Y.</given-names></name><name><surname>Xu</surname><given-names>B. X.</given-names></name></person-group><article-title>Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing trifluoromethyl</article-title><source><italic toggle="yes">Chinese Pharmaceutical Journal</italic></source><year>2019</year><volume>54</volume><issue>13</issue></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>X. Y.</given-names></name><name><surname>Zeng</surname><given-names>X. P.</given-names></name><name><surname>Wei</surname><given-names>K. X.</given-names></name><name><surname>Liang</surname><given-names>G. Y.</given-names></name><name><surname>Xu</surname><given-names>B. X.</given-names></name></person-group><article-title>Synthesis and anti-HBV activities of novel N-methylated derivatives of MTS</article-title><source><italic toggle="yes">Chinese Journal of Synthetic Chemistry</italic></source><year>2019</year><volume>27</volume><issue>4</issue><fpage>244</fpage><lpage>252</lpage></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>G. C.</given-names></name><name><surname>Hu</surname><given-names>Z. X.</given-names></name><name><surname>Zeng</surname><given-names>X. P.</given-names></name><name><surname>Liu</surname><given-names>Q. C.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name></person-group><article-title>Synthesis and anti-HBV activities of MTS derivatives of novel triantennary cluster galactoside</article-title><source><italic toggle="yes">Chinese Journal of Synthetic Chemistry</italic></source><year>2018</year><volume>26</volume><issue>3</issue><fpage>160</fpage><lpage>167</lpage></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X. X.</given-names></name><name><surname>Wu</surname><given-names>S. Z.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>C.</given-names></name><name><surname>Cen</surname><given-names>Z. J.</given-names></name></person-group><article-title>Screening of marine natural active small molecules against hepatitis B virus</article-title><source><italic toggle="yes">Modern Preventive Medicine</italic></source><year>2018</year><volume>45</volume><issue>23</issue><fpage>4335</fpage><lpage>4340</lpage></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H. N.</given-names></name><name><surname>Yin</surname><given-names>Z. F.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H. B.</given-names></name><name><surname>Zhao</surname><given-names>G. Q.</given-names></name></person-group><article-title>Chemical constituents from Pogonatherum crinitum and their anti-HBV activities in vitro</article-title><source><italic toggle="yes">Chinese Traditional Patent Medicine</italic></source><year>2019</year><volume>41</volume><issue>6</issue></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.-L.</given-names></name><name><surname>Cao</surname><given-names>T.-W.</given-names></name><name><surname>Jiang</surname><given-names>F.-Q.</given-names></name><etal/></person-group><article-title>Swerpunilactones A and B, the first example of xanthone and secoiridoid heterodimers from <italic>Swertia punicea</italic>, <italic>S. hispidicalyx</italic> , and <italic>S. yunnanensis</italic></article-title><source><italic toggle="yes">Tetrahedron Letters</italic></source><year>2013</year><volume>54</volume><issue>21</issue><fpage>2710</fpage><lpage>2712</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.03.057</pub-id><pub-id pub-id-type="other">2-s2.0-84876411264</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J. F.</given-names></name><name><surname>Wang</surname><given-names>Y. F.</given-names></name><name><surname>Bi</surname><given-names>Y. P.</given-names></name><name><surname>Li</surname><given-names>H. J.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name></person-group><article-title>Unusual nor-sesquiterpene lactone from the fruits of <italic>Illicium henryi</italic></article-title><source><italic toggle="yes">Tetrahedron Letters</italic></source><year>2013</year><volume>54</volume><issue>36</issue><fpage>4834</fpage><lpage>4836</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.06.081</pub-id><pub-id pub-id-type="other">2-s2.0-84881177405</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. J.</given-names></name><name><surname>Chou</surname><given-names>B. H.</given-names></name><name><surname>Lin</surname><given-names>C. W.</given-names></name><name><surname>Weng</surname><given-names>J. H.</given-names></name></person-group><article-title>Synthesis and antiviral effects of isosteviol-derived analogues against the hepatitis B virus</article-title><source><italic toggle="yes">Phytochemistry</italic></source><year>2014</year><volume>99</volume><issue>1</issue><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.12.014</pub-id><pub-id pub-id-type="other">2-s2.0-84894239751</pub-id><?supplied-pmid 24461778?><pub-id pub-id-type="pmid">24461778</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T.-J.</given-names></name><name><surname>Yang</surname><given-names>C.-L.</given-names></name><name><surname>Kuo</surname><given-names>Y.-C.</given-names></name><etal/></person-group><article-title>Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source><year>2015</year><volume>23</volume><issue>4</issue><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.12.064</pub-id><pub-id pub-id-type="other">2-s2.0-84964221932</pub-id><?supplied-pmid 25600408?><pub-id pub-id-type="pmid">25600408</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-L.</given-names></name><name><surname>Dai</surname><given-names>L.-H.</given-names></name><name><surname>Wu</surname><given-names>Y.-H.</given-names></name><etal/></person-group><article-title>Evaluation of hepatocyteprotective and anti-hepatitis B virus properties of Cichoric acid from Cichorium intybus leaves in cell culture</article-title><source><italic toggle="yes">Biological &#x00026; Pharmaceutical Bulletin</italic></source><year>2014</year><volume>37</volume><issue>7</issue><fpage>1214</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1248/bpb.b14-00137</pub-id><pub-id pub-id-type="other">2-s2.0-84904684717</pub-id><?supplied-pmid 24759764?><pub-id pub-id-type="pmid">24759764</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukamoto</surname><given-names>Y.</given-names></name><name><surname>Ikeda</surname><given-names>S.</given-names></name><name><surname>Uwai</surname><given-names>K.</given-names></name><name><surname>Taguchi</surname><given-names>R.</given-names></name><name><surname>Chayama</surname><given-names>K.</given-names></name><name><surname>Sakaguchi</surname><given-names>T.</given-names></name></person-group><article-title>Rosmarinic acid is a novel inhibitor for hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2018</year><volume>13</volume><issue>5, article e0197664</issue></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>J. M.</given-names></name><name><surname>Wan</surname><given-names>H. Q.</given-names></name><name><surname>Ge</surname><given-names>L. L.</given-names></name><name><surname>Zeng</surname><given-names>X. B.</given-names></name><name><surname>Peng</surname><given-names>S. S.</given-names></name></person-group><article-title>Anti-HBV activities of extracts and 3-caffeolquinic acid from Lonicera japonica Flower BudsJ</article-title><source><italic toggle="yes">Wuhan University Journal of Natural Sciences</italic></source><year>2019</year><volume>65</volume><issue>4</issue><fpage>352</fpage><lpage>356</lpage></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Geng</surname><given-names>C.-A.</given-names></name><name><surname>Ma</surname><given-names>Y.-B.</given-names></name><etal/></person-group><article-title>UFLC/MS-IT-TOF guided isolation of anti-HBV active chlorogenic acid analogues from <italic>Artemisia capillaris</italic> as a traditional Chinese herb for the treatment of hepatitis</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2014</year><volume>156</volume><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.08.043</pub-id><pub-id pub-id-type="other">2-s2.0-84908455492</pub-id><pub-id pub-id-type="pmid">25219603</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X. T.</given-names></name></person-group><article-title>Research progress on the bioactivity of plant polysaccharide</article-title><source><italic toggle="yes">Journal of Anhui Agricultural Sciences</italic></source><year>2008</year><volume>28</volume><fpage>12076</fpage><lpage>12077</lpage></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S. Y.</given-names></name><name><surname>Liu</surname><given-names>W. J.</given-names></name><name><surname>Cao</surname><given-names>Q. N.</given-names></name><name><surname>Ao</surname><given-names>C. J.</given-names></name></person-group><article-title>Research advancement in bioactivity of polysaccharides from plants</article-title><source><italic toggle="yes">Feed Industry</italic></source><year>2016</year><volume>22</volume><fpage>60</fpage><lpage>64</lpage></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>X. B.</given-names></name></person-group><article-title>Advances in the research of natural polysaccharides against hepatitis B virus</article-title><source><italic toggle="yes">World Latest Medicine Information</italic></source><year>2017</year><volume>17</volume><issue>20</issue></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L. Z.</given-names></name></person-group><article-title>Advances in extraction technology of Lentinan edodes</article-title><source><italic toggle="yes">Guangdong Chemical</italic></source><year>2015</year><volume>42</volume><issue>13</issue><fpage>138</fpage><lpage>139</lpage></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G. Q.</given-names></name><name><surname>Gai</surname><given-names>M. R.</given-names></name><name><surname>Yang</surname><given-names>J. Z.</given-names></name></person-group><article-title>The recent efficacy observation of 62 cases of chronic B viral hepatitis was treated by lamivudine</article-title><source><italic toggle="yes">The New Medicine</italic></source><year>2003</year><volume>34</volume><issue>4</issue><fpage>239</fpage><lpage>240</lpage></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.-M.</given-names></name><name><surname>Yang</surname><given-names>J.-m.</given-names></name><name><surname>Liu</surname><given-names>Y.-h.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Ultrasound assisted extraction of polysaccharides from <italic>Lentinus edodes</italic> and its anti-hepatitis B activity <italic>in vitro</italic></article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2018</year><volume>107</volume><issue>Part B</issue><fpage>2217</fpage><lpage>2223</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.10.100</pub-id><pub-id pub-id-type="other">2-s2.0-85031751395</pub-id><?supplied-pmid 29051096?><pub-id pub-id-type="pmid">29051096</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>M. Y.</given-names></name><name><surname>Huang</surname><given-names>R. B.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name></person-group><article-title>The inhibitory effects of polysaccharides from Hedyotis caudatifolia on hepatitis B virus</article-title><source><italic toggle="yes">Pharmacology and Clinics of Chinese Materia Medica</italic></source><year>2019</year><volume>35</volume><issue>4</issue><fpage>38</fpage><lpage>43</lpage></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>X. D.</given-names></name><name><surname>Wang</surname><given-names>K. X.</given-names></name><name><surname>Li</surname><given-names>C. P.</given-names></name></person-group><article-title>Study on the antihepatitis B virus effect of snail polysaccharide in vitro</article-title><source><italic toggle="yes">Chinese Journal of Experimental Traditional Medical Formulae</italic></source><year>2008</year><volume>14</volume><issue>3</issue><fpage>66</fpage><lpage>68</lpage></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L. F.</given-names></name></person-group><article-title>128 cases of chronic hepatitis B treated with polyporus polysaccharide and hepatitis B vaccine</article-title><source><italic toggle="yes">Journal of Clinical Medicine</italic></source><year>2009</year><volume>19</volume><issue>6</issue><fpage>15</fpage><lpage>16</lpage></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S. F.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Gui</surname><given-names>X. E.</given-names></name></person-group><article-title>Effects of angelica polysaccharide on the functional status of dendritic cells HBC trans-genic mice</article-title><source><italic toggle="yes">Journal of Practical Diagnosis and Therapy</italic></source><year>2005</year><volume>19</volume><issue>5</issue><fpage>313</fpage><lpage>317</lpage></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X. Y.</given-names></name><name><surname>Li</surname><given-names>C. P.</given-names></name><name><surname>Wang</surname><given-names>K. X.</given-names></name></person-group><article-title>Experimental study on polysaccharide of Cipangopaludina chinensis against HBV in vitro</article-title><source><italic toggle="yes">China Journal of Chinese Materia Medica</italic></source><year>2013</year><volume>38</volume><issue>6</issue><fpage>879</fpage><lpage>883</lpage><?supplied-pmid 23717972?><pub-id pub-id-type="pmid">23717972</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Q. F.</given-names></name><name><surname>Tan</surname><given-names>H. L.</given-names></name></person-group><article-title>Experimental study on the anti - hepatitis b virus effect of polysaccharides from paniculate</article-title><source><italic toggle="yes">Shandong Medical Journal</italic></source><year>2010</year><volume>50</volume><issue>7</issue><fpage>44</fpage><lpage>45</lpage></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X. L.</given-names></name><name><surname>Yang</surname><given-names>Y. D.</given-names></name><name><surname>Song</surname><given-names>C. B.</given-names></name><name><surname>Hu</surname><given-names>Z. H.</given-names></name><name><surname>Xu</surname><given-names>Y. P.</given-names></name></person-group><article-title>Synergy effect of oxymatrine on antiviral treatment of chronic hepatitis B</article-title><source><italic toggle="yes">Chinese Journal of Nosocomiology</italic></source><year>2019</year><volume>29</volume><issue>17</issue><fpage>2635</fpage><lpage>2638</lpage></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>HBV life cycle and therapeutic targets. HBV life cycle: adsorption, penetration, biosynthesis, assembly, and secretion; therapeutic targets: entry inhibitors (NTCP and HSPG as the receptor-virus binding), cccDNA inhibitors (inhibiting the information of cccDNA), Epi-drugs (inhibiting the viral RNA synthesis), endoplasmic reticulum inhibitors (inhibiting the viral capsid assembly), and glucosidese inhibitors (inhibiting the secretion of HBV proteins).</p></caption><graphic xlink:href="BMRI2020-3972390.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structures of representative anti-HBV phenylpropanoids <bold>1-14</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Chemical structures of representative anti-HBV flavonoids <bold>15-22</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structures of representative anti-HBV xanthones <bold>23</bold>-<bold>35</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Chemical structures of representative anti-HBV anthroquinones <bold>36-49.</bold></p></caption><graphic xlink:href="BMRI2020-3972390.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Chemical structures of representative anti-HBV terpenes <bold>50-97</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Chemical structures of representative anti-HBV alkaloids <bold>98-104</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.007"/></fig><fig id="fig8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Chemical structures of representative anti-HBV enediynes <bold>105-120</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.008"/></fig><fig id="fig9" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Chemical structures of representative anti-HB Varomatics <bold>121-132</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.009"/></fig><fig id="fig10" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Chemical structures of representative anti-HBV phenylalanine dipeptides <bold>133-151</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.010"/></fig><fig id="fig11" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Chemical structures of representative anti-HBV compounds <bold>152</bold>-<bold>165</bold>.</p></caption><graphic xlink:href="BMRI2020-3972390.011"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The compounds with anti-HBV effects from natural products.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Compound</th><th align="center" rowspan="1" colspan="1">Target</th><th align="center" rowspan="1" colspan="1">Source</th><th align="center" rowspan="1" colspan="1">Ref</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6-Hydroxyl-7-methoxyl-coumarin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B19" ref-type="bibr">19</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">Esculetin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>M. fortunei</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">Magnatriol B</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">Honokiol</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">Isomagnolol</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">isocarpine</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">Honokiol</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">(7&#x02032;<italic>R</italic>, 8&#x02032;<italic>S</italic>, 7&#x02032;<italic>R</italic>, 8&#x02032;<italic>S</italic>)-erythron-Strebluslignanol G</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">Coumarin lignan</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>K. heteroclita</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B24" ref-type="bibr">24</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">Niranthin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. niruri</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B25" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">(+)-Dehydrod-iconiferyl alcohol</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. patens</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">Dehydrozingerone</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. patens</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">(+)-Cycloolivil-4&#x02032;-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. chirayita</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">Syringaresinol 4-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. chirayita</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">Luteolin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. macrosperma</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B29" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">Isovitexin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">LPRP-Et-97543</td><td align="center" rowspan="1" colspan="1">Core, S, and preS promoters</td><td align="center" rowspan="1" colspan="1">
<italic>L. muscari</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">Quercetin</td><td align="center" rowspan="1" colspan="1">HBeAg</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">Glabaarachalcone</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. pinnata</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">Isopongachromene</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. pinnata</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">Isooriention</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">Epimedium Hyde II</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B35" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">Norbellidifolin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1,5,8-Trihydroxy-3-methoxyxanthone</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">2-C-<italic>&#x003b2;</italic>-D-glucopyranosyl-1,3,7-trihydroxyxanthone</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">Norswertianolin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">Norswertianin-1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucoside</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">1,7-Dihydroxy-3,8-dimethoxyxanthone</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">7-<italic>O</italic>-[<italic>&#x003b2;</italic>-D-xylopyranosyl-(1&#x02192;2)-<italic>&#x003b2;</italic>-D-xylopyranosyl]-1,8-dihydroxy-3-methoxyxanthone</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">Mangiferin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">Methyl6,8-dihydroxy-3-methyl-9-oxo-9H-xanthene-1-carboxylate</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">1,8-Dihydroxy-3,5-dimethoxyxanthone</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">Norswertianolin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">Neolancerin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">1,5,8-Trihydroxy-3-methoxyxanthone</td><td align="center" rowspan="1" colspan="1">HBeAg and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. delavayi</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">(&#x02212;)-2&#x02032;<italic>R</italic>-1-hydroxyisorhodoptilometrin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">Asterric acid</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">Questinol</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">Endocrocin</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">(+)-2&#x02032;<italic>S</italic>-isorhodoptilometrin</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">Sulochrin</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">Monochlorsulochrin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">Dihydrogeodin</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>Penicillium</italic> sp.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">1,3-Dihydroxy-2-hydroxymethyl-9,10-anthraquinone</td><td align="center" rowspan="1" colspan="1">HBeAg and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. connata</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">Rubiadin</td><td align="center" rowspan="1" colspan="1">HBeAg, HBsAg, HBx, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. connata</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">Anthraquinone bile acid conjugates</td><td align="center" rowspan="1" colspan="1">HBeAg and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. connata</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">Aloin B</td><td align="center" rowspan="1" colspan="1">HBV-DNA polymerase</td><td align="center" rowspan="1" colspan="1">
<italic>Aloe vera</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">Aloe-emodin</td><td align="center" rowspan="1" colspan="1">CYP3A4</td><td align="center" rowspan="1" colspan="1">
<italic>Aloe vera</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">Hypericin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, HBV-DNA, and pgRNA</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B42" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">Ursolic acid</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. asper</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B19" ref-type="bibr">19</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">MH</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>V. tenuifolia</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B44" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">Sweriyunnangenin A</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">3-Epitaraxerol</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">Oleanolic acid</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">Erythrocentaurin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. yunnanensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">Astataricusones B</td><td align="center" rowspan="1" colspan="1">HBeAg, HBV-DNA, and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>A. tataricus</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">Epishionol</td><td align="center" rowspan="1" colspan="1">HBeAg and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. tataricus</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">Astershionones C</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. tataricus</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B46" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">4<sup>&#x02033;</sup>-Hydrox<sup>&#x02033;</sup>y-3<sup>&#x02033;</sup>-methoxyalbiflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">6&#x02032;-<italic>O</italic>-<italic>p</italic>-hydroxybenzoyl-4<sup>&#x02033;</sup>-Hydroxyalbiflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">Albiflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">Oxypaeoniflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">Paeoniflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">Paeonins B</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">Benzoylpaeoniflorin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>P. sinjiangensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">Perovskatone A</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. atriplicifolia</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">Demethylsalvicanol</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. atriplicifolia</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">Chrysanolide B</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>D. indicum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">Chrysanolide C</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>D. indicum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">Chrysanolide A</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>D. indicum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">Pimelotide A</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. elongata foliage</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B50" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">Wikstroelide W</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">73</td><td align="center" rowspan="1" colspan="1">Genkwanine P</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">laurifolioside A</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">2-Epi-laurifolioside A</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">Laurifolioside B</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">77</td><td align="center" rowspan="1" colspan="1">2-Epi-laurifolioside B</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">Laurifolioside</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">79</td><td align="center" rowspan="1" colspan="1">2-epi-laurifolioside</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>W. chamaedaphne</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">Oleanolic acid 3-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucuronopyranoside</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A.philoxeroides</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">81</td><td align="center" rowspan="1" colspan="1">4,5-Dihydroblumenol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A.philoxeroides</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">Swericinctosides A</td><td align="center" rowspan="1" colspan="1">HBV-DNA and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">Swericinctoside B</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">9-Epi swertiamarin</td><td align="center" rowspan="1" colspan="1">HBV-DNA and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">2&#x02032;-<italic>O</italic>-m-hydroxybenzoyl swertiamarin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">4<sup>&#x02033;</sup>-<italic>O</italic>-actyl swertianoside E</td><td align="center" rowspan="1" colspan="1">HBV-DNA and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">Swertiaside</td><td align="center" rowspan="1" colspan="1">HBV-DNA and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">Swertianoside C</td><td align="center" rowspan="1" colspan="1">HBV-DNA and HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">Decentapicrin B</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. cincta</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">ET derivatives 1e</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B54" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">ET derivatives 1f</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B54" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">Swertiakoside A</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. delavayi</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">93</td><td align="center" rowspan="1" colspan="1">2&#x02032;-<italic>O</italic>-acetylswertiamarin</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. delavayi</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">94</td><td align="center" rowspan="1" colspan="1">Asiaticoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>H. sibthorpioides</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B55" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">Diosgenin</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">7-Eudesm-4(15)-ene-1<italic>&#x003b2;</italic>,6<italic>&#x003b1;</italic>-diol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B57" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">Pumilaside A</td><td align="center" rowspan="1" colspan="1">HBeAg, HBsAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B57" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">Erythro-1-[1-oxo-9(3,4-methylenedioxyphenyl)-8,9-dihydroxy-2<italic>E</italic>-nonenyl]-piperidine</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">99</td><td align="center" rowspan="1" colspan="1">Threo-1-[1-oxo-9(3,4-methylenedioxyphenyl)-8,9-dihydroxy-2<italic>E</italic>-nonenyl]-piperidine</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">Piperine</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">101</td><td align="center" rowspan="1" colspan="1">Guineesine</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">102</td><td align="center" rowspan="1" colspan="1">(2<italic>E</italic>,4<italic>E</italic>)-N-isobutyleicosa-2,4-dienamide</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">103</td><td align="center" rowspan="1" colspan="1">3<italic>&#x003b2;</italic>,4<italic>&#x003b1;</italic>-dihydroxy-1-(3-phenylpropanoyl)-piperidine-2-one</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. longum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B60" ref-type="bibr">60</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">104</td><td align="center" rowspan="1" colspan="1">DHCH</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, cccDNA, and DNA</td><td align="center" rowspan="1" colspan="1">
<italic>C. saxicola</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B61" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">105</td><td align="center" rowspan="1" colspan="1">8<italic>S</italic>-deca-9-en-4,6-diyne-1,8-diol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1">(<italic>S</italic>)-deca-4,6,8-triyne-1,3-diol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">107</td><td align="center" rowspan="1" colspan="1">(<italic>S</italic>)-3-hydroxyundeca-5,7,9-triynoic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">108</td><td align="center" rowspan="1" colspan="1">3<italic>S</italic>-Hydroxyundeca-5,9-triynoic acid 3-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1">Atractylodin</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">110</td><td align="center" rowspan="1" colspan="1">Dendroarboreol B</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">111</td><td align="center" rowspan="1" colspan="1">Dehydrofalcarinol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">112</td><td align="center" rowspan="1" colspan="1">Dehydrofalcarindiol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">113</td><td align="center" rowspan="1" colspan="1">(<italic>E</italic>)-deca-2-en-4,10-diol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">114</td><td align="center" rowspan="1" colspan="1">(<italic>Z</italic>)-deca-2-en-4,10-diol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">115</td><td align="center" rowspan="1" colspan="1">8-Diol 1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">116</td><td align="center" rowspan="1" colspan="1">3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-ene-4,6-diyne1-<italic>O</italic>-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">117</td><td align="center" rowspan="1" colspan="1">5-Benzylthiophencarboxylic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">118</td><td align="center" rowspan="1" colspan="1">2-Methyl-6-phenyl-4H-pyran-4-one</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">119</td><td align="center" rowspan="1" colspan="1">3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-en-4,6-yne 1-<italic>O</italic>-(6&#x02032;-<italic>O</italic>-caffeoyl)-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">120</td><td align="center" rowspan="1" colspan="1">3<italic>S</italic>,8<italic>S</italic>-dihydroxydec-9-en-4,6-yne1-<italic>O</italic>-(2&#x02032;-<italic>O</italic>-caff-eoyl)-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">121</td><td align="center" rowspan="1" colspan="1">
<italic>m</italic>-Hydroxybenzoic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">122</td><td align="center" rowspan="1" colspan="1">
<italic>p</italic>-Hydroxybenzoic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">
<italic>m</italic>-Hydroxy benzenmethanol</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">124</td><td align="center" rowspan="1" colspan="1">3,4-Dihydroxybenzoic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">Ethyl 3,4-dihydroxybenzoate</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">126</td><td align="center" rowspan="1" colspan="1">Ethyl 2,5-dihydroxybenzoate</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. mussotii</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">127</td><td align="center" rowspan="1" colspan="1">3,3&#x02032;,5-Trihydroxybiphenyl</td><td align="center" rowspan="1" colspan="1">HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>S. chirayita</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">TaraffinisosideA</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>T. affinis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">Descaffeoyl crenatoside</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>T. affinis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">130</td><td align="center" rowspan="1" colspan="1">3,4-Dihydroxyphenylethanol-8-<italic>O</italic>-[<italic>&#x003b2;</italic>-D-apiofuranosyl (1&#x02192;3)]-<italic>&#x003b2;</italic>-D-glucopyranoside</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>T. affinis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">131</td><td align="center" rowspan="1" colspan="1">
<italic>p</italic>-Hydroxy acetophenone (PHAP)</td><td align="center" rowspan="1" colspan="1">HBsAg</td><td align="center" rowspan="1" colspan="1">
<italic>A. morrisonensis</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B66" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">132</td><td align="center" rowspan="1" colspan="1">
<italic>p</italic>-HAP derivative 2f</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. capillaris</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B67" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">Matijin-Su</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>D. repens</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B68" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">134</td><td align="center" rowspan="1" colspan="1">N-[N-(3,4-dimethoxy-benzoyl)-L-phenylalanyl]-<italic>O</italic>-propionyl-L-phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B71" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">N-[N-(3,4-dimethoxy-benzoyl)-L-phenylalanyl]-4-ethoxy-L-phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B71" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1">N-[N-(3,4-Dimethoxy-benzoyl)-L-phenylalanyl]-4-ethoxycarbonylmethyl-L-tyrosinol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B71" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">137</td><td align="center" rowspan="1" colspan="1">N-[N-(4-chlorobenzoyl)-<italic>O</italic>-methyl-L-tyrosyl]-L-Phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B72" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">138</td><td align="center" rowspan="1" colspan="1">N-[N-(4-chlorobenzoyl)-<italic>O</italic>-propyl-L-tyrosyl]-L-Phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B72" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">139</td><td align="center" rowspan="1" colspan="1">N-[N-(4-chlorobenzoyl)-<italic>O</italic>-isopropyl-L-tyrosyl]-L-Phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B72" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">140</td><td align="center" rowspan="1" colspan="1">N-[N-(3-trifluoromethylbenzoyl)-L-tyrosyl]-L-Phenylalaninol</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B73" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">141</td><td align="center" rowspan="1" colspan="1">N-[N-(3-trifluoromethylbenzoyl)-L-phenylalanyl]-<italic>O</italic>-propionyl-L-tyrosine methyl ester</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B73" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">142</td><td align="center" rowspan="1" colspan="1">N-[N-(3-trifluoromethylbenzoyl)-L-phenylalanyl]-<italic>O</italic>-ethyl-L-tyrosine</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B73" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">143</td><td align="center" rowspan="1" colspan="1">Compound 8n</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B74" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">144</td><td align="center" rowspan="1" colspan="1">Compound 8o</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B74" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">145</td><td align="center" rowspan="1" colspan="1">Compound 9 a</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B75" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">146</td><td align="center" rowspan="1" colspan="1">Compound 9 b</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B75" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">Compound 9 c</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B75" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">148</td><td align="center" rowspan="1" colspan="1">Cyclic (glycine-L-proline)</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">149</td><td align="center" rowspan="1" colspan="1">Cyclic (4-hydroxy proline-phenylalanine)</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">Cyclic (L-2-hydroxy proline-phenylalanine)</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">N-acetyl phenylalanine</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>P. crinitum</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B77" ref-type="bibr">77</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">152</td><td align="center" rowspan="1" colspan="1">Two dimers of oxanthrone</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. punicea</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B78" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">153</td><td align="center" rowspan="1" colspan="1">Iridoid lactone</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>S. punicea</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B78" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">154</td><td align="center" rowspan="1" colspan="1">Anislactone B</td><td align="center" rowspan="1" colspan="1">HBeAg</td><td align="center" rowspan="1" colspan="1">
<italic>I. henryi</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B79" ref-type="bibr">79</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">155</td><td align="center" rowspan="1" colspan="1">NC-8</td><td align="center" rowspan="1" colspan="1">HBsAg and HBeAg</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B80" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">156</td><td align="center" rowspan="1" colspan="1">IN-4</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">Synthesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B81" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1">Scoparamide A</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>A. scoparia</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">158</td><td align="center" rowspan="1" colspan="1">Cichoric acid</td><td align="center" rowspan="1" colspan="1">DHBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>C. intybus</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B82" ref-type="bibr">82</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">159</td><td align="center" rowspan="1" colspan="1">Rosmarinic acid</td><td align="center" rowspan="1" colspan="1">
<italic>&#x003b5;</italic>-Pol binding</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">[<xref rid="B83" ref-type="bibr">83</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">3-Caffeoylquinicacid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">161</td><td align="center" rowspan="1" colspan="1">Cryptochlorogenic acid</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">162</td><td align="center" rowspan="1" colspan="1">Neochlorogenic acid</td><td align="center" rowspan="1" colspan="1">HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">163</td><td align="center" rowspan="1" colspan="1">3,5-Dicaffeoylquinic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">164</td><td align="center" rowspan="1" colspan="1">4,5-Dicaffeoylquinic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">165</td><td align="center" rowspan="1" colspan="1">3,4-Dicaffeoylquinic acid</td><td align="center" rowspan="1" colspan="1">HBsAg, HBeAg, and HBV-DNA</td><td align="center" rowspan="1" colspan="1">
<italic>L. japonica</italic>
</td><td align="center" rowspan="1" colspan="1">[<xref rid="B84" ref-type="bibr">84</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>